Professor David Celermajer

Scandrett Professor of Cardiology
Medicine, Central Clinical School
Heart Research Institute

Telephone +61 2 9515 7110
Fax +61 2 9550 6262

Map

Biographical details

Professor David Celermajer MBBS MSc PhD DSc FAHA FRACP FAA
David Celermajer is the Scandrett Professor of Cardiology at The University of Sydney and Director of Echocardiography in the Cardiology Department at Royal Prince Alfred Hospital, as well as Staff Cardiologist at the Children's Hospital in Westmead. He has been Group Leader of the Clinical Research Group of the the Heart Research Institute since 1994, and in 2003 was appointed as Clinical Director of the Heart Research Institute. He sits on the National Heart Foundation of Australia's Cardiovascular Health Advisory Committee and is currently also a Board Member of the Menzies School of Health Research in the Northern Territory. Since 2006 he has been a Fellow of the Australian Academy of Science. Dux of Sydney Grammar School Rhodes Scholar for NSW 1983 University Medallist, USyd Medicine, 1984 World Debating and Public Speaking Champion 1984 Winner of RT Hall Prize and Eric Susman Medal for Research, 1998 Winner of Commonwealth Health Minister's Award for Health Research 2002 Fellow of the Australian Academy of Science 2006 Sir Kempson Maddox Lecturer, Cardiac Society of ANZ 2008

Research interests

We have 3 main types of research endeavour;

1. Basic Science - the cell and molecular biology of atherosclerosis, especially endothelial adhesiveness and foam cell macrophage biology 2. Clinical research - mainly on non-invasive methods to assess arterial structure and function to detect early signs of vascular disease (especially endothelial dysfunction) 3. Public Health research in developing nations - we collaborate on projects dealing with atherosclerosis in China and India; Rheumatic Heart Disease in Africa and Asia; and malaria-related vascular dysfunction in Indonesia.

International links

China

(Chinese University of Hong Kong) Longstanding research collaboration

Finland

(Turku University) Professor Olli Raitakari

France

(George Pompidou Centre, Paris) Professor Xavier Jouven

France

(Hopital Necker) Longstanding research collaborations

France

(Hopital Necker, Paris) Professor Daniel Sidi

Hong Kong S.A.R.

(Chinese University of Hong Kong) Professor K S Woo, Department of Cardiology

United Kingdom

(Great ormond Street Hospital, London) Longstanding research collaborations

United Kingdom

(Institute of Child Health, London) Professor John Deanfield

Selected grants

2013

  • Screening of Fontan patients in Australia & New Zealand for long-term liver and kidney damage; Celermajer D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Atherosclerosis - the key roles of HDL, cell cholesterol metabolism and vascular function; Barter P, Celermajer D, Rye K, Kritharides L, Jessup W; National Health and Medical Research Council (NHMRC)/Program Grants.
  • Atherosclerosis - the key roles of HDL, cell cholesterol metabolism and vascular function; Barter P, Celermajer D, Rye K, Kritharides L, Jessup W; National Health and Medical Research Council (NHMRC)/Program Grants.

2012

  • CardioCAPS: Determining the effects of the transition through puberty on vascular structure and function at age 14 years; Ayer J, Celermajer D; Financial Markets Foundation for Children/Research Support.
  • NOVEL NON-INVASIVE METHODS FOR THE EARLY DETECTION OF PULMONARY VASCULAR DISEASE; Celermajer D, Corte T, Bailey D; National Health and Medical Research Council (NHMRC)/Project Grants.

2010

  • Congenital and inherited heart diseases: towards a comprhensive life management plan; Celermajer D, Winlaw D; Heart Foundation of Australia/Cardiovascular Disease and Depression Strategic Research Program.
  • Dr Berni Changsiri part-time PhD candidates project: Indoleamine 2,3-dioxgenase in the novel regulation of vascular tone :; Stocker R, Celermajer D; Pfizer Australia Pty Ltd/Cardio Vascular Lipid Research Grants (CVL).
  • Eyes, endothelial function and exercise performance in cyanotic congenital heart disease; Celermajer D, Cordina R; Sydney South West Area Health Service/Research Support.

2008

  • Invasive Assessment of Pulmonary Vascular Physiology - Noel Methods for Early Detection of Pulmonary Vascular Disease; Celermajer D, Ng M; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Atherosclerosis: Lipoproteins, cell biology and vascular physiology; Barter P, Barter P, Celermajer D; National Health and Medical Research Council (NHMRC)/Program Grants.

2006

  • Nitric oxide and sympathetic reflex control of blood pressure; Sanders M, Celermajer D, Macefield V; National Heart Foundation/Research Grant.
  • CardioCAPS- a study of omega-3 dietary supplementation in children; Celermajer D, Ayer J; Pfizer Australia/Cardiovascular Lipid Research Grant.

2004

  • CDAH project; Celermajer D, Dwyer, T, Venning A; National Heart Foundation/Childhood Determinants of Adult Health (CDAH).
  • Terason notebook digital ultrasound system with vascular and cardiac configurations; O'Dea K, Celermajer D, Neal B, Anstey N; National Health and Medical Research Council (NHMRC)/Equipment Grants.
  • Fibrosis and diastolic dysfunction in diabetes mellitus; Celermajer D, Twigg S; Diabetes Australia/Research Grant.

2003

  • Androgens and atherosclerosis; Handelsman D, Celermajer D, Heather A; National Heart Foundation/Research Grant.
  • Atherosclerosis : Lipoproteins, cell biology and vascular physiology; Stocker R, Barter P, Rye K, Barter P, Celermajer D, Jessup W, Rye K; National Health and Medical Research Council (NHMRC)/Program Grants.

2002

  • Mechanisms of pro-atherogenic effects of androgens in human vascular cells; Heather A, Celermajer D, Handelsman D; Heart Research Institute/Research Grant.
  • Non-invasive detection of early vascular disease and assessment of reversibility in adults prone to atherosclerosis; Celermajer D; Medical Research Foundation/Research Project Support.
  • Effect of dietary fatty acid supplementation on high density lipoprotein phospholipid composition an; Nicholls S, Rye K, Celermajer D; Pfizer Australia/Cardiovascular Lipid Research Grant.
  • The role of physiology of the coronary microcirculation in ischaemic heart disease; Celermajer D, Adams M, Kilian J; National Heart Foundation/Research Grant.

2001

  • The role of repetitive hypoxia in vascular disease; Wilcox I, Jeremy R, Celermajer D; National Heart Foundation/Research Grant.
  • Accelerated atherosclerosis in renal failure; Celermajer D, Woo Kam S; Research Grants Committee of Hong Kong (China)/Research Grant.

2000

  • Vascular reactivity substudy; Celermajer D, Keech A; FIELD/Not Known.

1999

  • Androgens and atherosclerosis; Celermajer D, Handelsman D, Heather A; Merck Pty Limited/Merck Medical Schools Grant.
  • Strain imaging in the heart; Celermajer D; GE Vingmed/Research Project.
  • Raloxifene and vascular physiology; Celermajer D; Eli Lilly Australia Pty Limited/Project Support.

1996

  • Medical Foundation Program Grant; Celermajer D; University of Sydney/Medical Foundation Program Grant.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Celermajer, D., Deanfield, J. (2003). Congenital heart disease in adolescents and adults. (CHD in Adolescence). In Anderson RH, Tynan M, Rigby M (Eds.), Paediatric Cardiology, (pp. 1893-1925). London: Churchill Livingstone.
  • Celermajer, D., Deanfield, J. (2003). Diseases of the tricuspid valve. In Anderson RH, Tynan M, Rigby M (Eds.), Paediatric Cardiology, (pp. 1111-1133). London: Churchill Livingstone.
  • Rasko, J., Celermajer, D. (2000). Gene therapy for vascular diseases. In RT Dean, D Kelly (Eds.), Atherosclerosis: Gene Expression, Cell Interactions, and Oxidation, (pp. 112-136). Oxford: Oxford University Press.
  • Celermajer, D., Vita, J. (2000). Vascular dysfunction and its contribution to atherogenesis. In RT Dean, D Kelly (Eds.), Atherosclerosis: Gene Expression, Cell Interactions, and Oxidation, (pp. 88-111). Oxford: Oxford University Press.

Journals

  • Dunn, L., Simpson, P., Prosser, H., Lecce (Venuto), L., Yuen, S., Buckle, A., Sieveking, D., Vanags, L., Lim, P., Chow, R., Bao, B., Davies, M., Celermajer, D., Bursill, C., Ng, M., et al (2014). A Critical Role for Thioredoxin Interacting Protein in Diabetes-Related Impairment of Angiogenesis. Diabetes, 63(2), 675-687. [More Information]
  • Ganigara, M., Collins, N., Tanous, D., Celermajer, D., Puranik, R. (2014). Anomalous left anterior descending coronary artery from the pulmonary artery - The role of cardiac MRI. International Journal of Cardiology, 172(1), e172-e174. [More Information]
  • Chow, V., Yeoh, T., Ng, A., Pasqualon, T., Scott, E., Plater, J., Whitwell, B., Hanzek, D., Chung, T., Thomas, L., Celermajer, D., Kritharides, L. (2014). Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia:a multicentre cross-sectional cohort study. Open Heart, 1, 1-10. [More Information]
  • Cordina, R., Grieve, S., Barnett, M., Lagopoulos, J., Malitz, N., Celermajer, D. (2014). Brain volumetric, regional cortical thickness and radiographic findings in adults with cyanotic congenital heart disease. NeuroImage: Clinical, 4, 319-325. [More Information]
  • Padang, R., Dennis, M., Semsarian, C., Bannon, P., Tanous, D., Celermajer, D., Puranik, R. (2014). Detection of Serious Complications by MR Imaging in Asymptomatic Young Adults with Repaired Coarctation of the Aorta. Heart, Lung and Circulation, 23(4), 332-338. [More Information]
  • Skilton, M., Siitonen, N., Wurtz, P., Viikari, J., Juonala, M., Seppala, I., Laitinen, T., Lehtimaki, T., Taittonen, L., Kahonen, M., Celermajer, D., et al (2014). High birth weight is associated with obesity and increased carotid wall thickness in young adults: the cardiovascular risk in young Finns study. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(5), 1064-1068. [More Information]
  • McGrath, K., Li, X., Whitworth, P., Kasz, R., Tan, J., McLennan, S., Celermajer, D., Barter, P., Rye, K., Heather, A. (2014). High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation. Journal of Lipid Research (Online), 55(3), 421-430. [More Information]
  • Kapellas, K., Skilton, M., Maple-Brown, L., Do, L., Bartold, P., O'Dea, K., Brown, A., Celermajer, D., Jamieson, L. (2014). Periodontal disease and dental caries among Indigenous Australians living in the Northern Territory, Australia. Australian Dental Journal, 59(1), 93-99. [More Information]
  • Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P., Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT study. Heart, 100(1), 47-53. [More Information]
  • O'Meagher, S., Ganigara, M., Munoz, P., Tanous, D., Chard, R., Celermajer, D., Puranik, R. (2014). Right Ventricular Outflow Tract Enlargement Prior to Pulmonary Valve Replacement is Associated with Poorer Structural and Functional Outcomes, in Adults with Repaired Tetralogy of Fallot. Heart, Lung and Circulation, 23(5), 482-488. [More Information]
  • Iyengar, A., Winlaw, D., Galati, J., Gentles, T., Weintraub, R., Justo, R., Wheaton, G., Bullock, A., Celermajer, D., d'Udekem, Y. (2014). The Australia and New Zealand Fontan Registry: description and initial results from the first population-based Fontan registry. Internal Medicine Journal, 44(2), 148-155. [More Information]
  • Skilton, M., Sullivan, T., Ayer, J., Garden, F., Harmer, J., Leeder, S., Toelle, B., Webb, K., Marks, G., Celermajer, D. (2014). Weight gain in infancy is associated with carotid extra-medial thickness in later childhood. Atherosclerosis, 233(2), 370-374. [More Information]
  • Lau, E., Morgan, P., Belousova, E., Toelle, B., Ayer, J., Celermajer, D., Marks, G. (2013). Asymmetric dimethylarginine and asthma: results from the Childhood Asthma Prevention Study. The European Respiratory Journal, 41(5), 1234-1237. [More Information]
  • Low, A., Celermajer, D. (2013). Author reply. Internal Medicine Journal, 43(5), 609-609. [More Information]
  • O'Meagher, S., Choudhary, P., Duflou, J., Puranik, R., Celermajer, D. (2013). Causes of death in tetralogy of Fallot in adults - An autopsy study. International Journal of Cardiology, 168(2), 1547-1548. [More Information]
  • Marijon, E., Bougouin, W., Celermajer, D., Perier, M., Dumas, F., Benameur, N., Karam, N., Lamhaut, L., Tafflet, M., Mustafic, H., et al (2013). Characteristics and outcomes of sudden cardiac arrest during sports in women. Circulation. Arrhythmia and Electrophysiology, 6(6), 1185-1191. [More Information]
  • Levy, M., Bonnet, D., Mauge, L., Celermajer, D., Gaussem, P., Smadja, D. (2013). Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening. PLoS One, 8(6), 1-10. [More Information]
  • Levy, M., Celermajer, D., Szezepanski, I., Boudjemline, Y., Bonnet, D. (2013). Do tertiary paediatric hospitals deal with the same spectrum of paediatric pulmonary hypertension as multicentre registries? The European Respiratory Journal, 41(1), 236-239. [More Information]
  • Simpson, P., Hoyos, C., Celermajer, D., Liu, P., Ng, M. (2013). Effects of continuous positive airway pressure on endothelial function and circulating progenitor cells in obstructive sleep apnoea: A randomised sham-controlled study. International Journal of Cardiology, 168(3), 2042-2048. [More Information]
  • Kapellas, K., Do, L., Bartold, M., Skilton, M., Maple-Brown, L., O'Dea, K., Brown, A., Celermajer, D., Slade, G., Jamieson, L. (2013). Effects of full-mouth scaling on the periodontal health of Indigenous Australians: a randomized controlled trial. Journal of Clinical Periodontology, 40(11), 1016-1024. [More Information]
  • Beurtheret, S., Mordant, P., Paoletti, X., Marijon, E., Celermajer, D., Leger, P., Pavie, A., Combes, A., Leprince, P. (2013). Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). European Heart Journal, 34(2), 112-120. [More Information]
  • Celermajer, D., Neal, B. (2013). Excessive Sodium Intake and Cardiovascular Disease: A-Salting Our Vessels. Journal of the American College of Cardiology, 61(3), 344-345. [More Information]
  • Skilton, M., Mikkila, V., Wurtz, P., Ala-Korpela, M., Sim, K., Soininen, P., Kangas, A., Viikari, J., Juonala, M., Laitinen, T., Celermajer, D., et al (2013). Fetal growth, omega-3 (n-3) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The Cardiovascular Risk in Young Finns Study 1–3. The American Journal of Clinical Nutrition, 97(1), 58-65. [More Information]
  • Plichart, M., Thomas, F., Empana, J., Bean, K., Perier, M., Celermajer, D., Hanona, O., Danchin, N., Pannier, B., Jouven, X. (2013). Gender-specific trends in heart rate in the general population from 1992-2007: a study of 226,288 French adults. European Journal of Preventive Cardiology, 20(1), 61-72. [More Information]
  • Skilton, M., Raitakari, O., Celermajer, D. (2013). High Intake of Dietary Long-Chain {omega}-3 Fatty Acids Is Associated With Lower Blood Pressure in Children Born With Low Birth Weight: NHANES 2003-2008. Hypertension, 61(5), 972-976. [More Information]
  • Canniffe, C., Ou, P., Walsh, K., Bonnet, D., Celermajer, D. (2013). Hypertension after repair of aortic coarctation - A systematic review. International Journal of Cardiology, 167(6), 2456-2461. [More Information]
  • Hu, Y., Wei, A., Chook, P., Yin, Y., Cheng, W., Wu, M., Celermajer, D., Woo, K. (2013). Impact of non-cardiovascular surgery on reactive hyperaemia and arterial endothelial function. Clinical and Experimental Pharmacology and Physiology, 40(7), 466-472. [More Information]
  • Marijon, E., Bougouin, W., Perier, M., Celermajer, D., Jouven, X. (2013). Incidence of sports-related sudden death in France by specific sports and sex. JAMA, 310(6), 642-643. [More Information]
  • Marijon, E., Bougouin, W., Celermajer, D., Perier, M., Benameur, N., Lamhaut, L., Karam, N., Dumas, F., Tafflet, M., Prugger, C., et al (2013). Major regional disparities in outcomes after sudden cardiac arrest during sports. European Heart Journal, 34(47), 3632-3640. [More Information]
  • Ou, P., Khraiche, D., Celermajer, D., Agnoletti, G., Le Quan Sang, K., Thalabard, J., Quintin, M., Raisky, O., Vouhe, P., Sidi, D., et al (2013). Mechanisms of coronary complications after the arterial switch for transposition of the great arteries. The Journal of Thoracic and Cardiovascular Surgery, 145(5), 1263-1269. [More Information]
  • Marijon, E., Tafflet, M., Antero-Jacquemin, J., El Helou, N., Berthelot, G., Celermajer, D., Bougouin, W., Combes, N., Hermine, O., Empana, J., et al (2013). Mortality of French participants in the Tour de France (1947-2012). European Heart Journal, 34(40), 3145-3150. [More Information]
  • O'Meagher, S., Celermajer, D., Puranik, R. (2013). Preserved stroke volume late after tetralogy repair, despite severe right ventricular dilatation. Heart, 99(24), 1875-1876. [More Information]
  • Lau, E., Jaijee, S., Melehan, K., Wong, K., Yee, B., Grunstein, R., Celermajer, D. (2013). Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. International Journal of Cardiology, 165(1), 35-40. [More Information]
  • Cordina, R., O'Meagher, S., Karmali, A., Rae, C., Liess, C., Kemp, G., Puranik, R., Singh, N., Celermajer, D. (2013). Resistance training improves cardiac output, exercise capacity and tolerance to positive airway pressure in Fontan physiology. International Journal of Cardiology, 168(2), 780-788. [More Information]
  • Jaijee, S., O'Rourke, R., Puranik, R., Slaughter, R., Strugnal, W., Celermajer, D., Kermeen, F. (2013). Right to left ventricular volume ratio: A novel marker of disease severity in chronic thromboembolic pulmonary hypertension. IJC Heart & Vessels, 1, 17-21. [More Information]
  • Low, A., Fowler, D., Manghani, M., Young, I., Garsia, R., Torzillo, P., Youssef, P., Celermajer, D. (2013). Screening and Treating Pulmonary Arterial Hypertension in a Tertiary Hospital-based Multidisciplinary Clinic: The First 200 Patients. Internal Medicine Journal, 43(1), 32-37. [More Information]
  • Cordina, R., O'Meagher, S., Gould, H., Rae, C., Kemp, G., Pasco, J., Celermajer, D. (2013). Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation. Heart, 99(20), 1530-1534. [More Information]
  • Ladouceur, M., Kachenoura, N., Lefort, M., Redheuil, A., Bonnet, D., Celermajer, D., Iserin, L., Mousseaux, E. (2013). Structure and function of the ascending aorta in palliated transposition of the great arteries. International Journal of Cardiology, 165(3), 458-462. [More Information]
  • Offen, S., Celermajer, D., Semsarian, C., Puranik, R. (2013). The role of diastolic filling in preserving left ventricular stroke volume - An MRI study. International Journal of Cardiology, 168(2), 1596-1598. [More Information]
  • Schuuring, M., Bouma, B., Cordina, R., Gatzoulis, M., Budts, W., Mullen, M., Vis, J., Celermajer, D., Mulder, B. (2013). Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. International Journal of Cardiology, 164(1), 106-110. [More Information]
  • Blyton, D., Skilton, M., Edwards, N., Hennessy, A., Celermajer, D., Sullivan, C. (2013). Treatment of sleep disordered breathing reverses low fetal activity levels in preeclampsia. Sleep, 36(1), 15-21. [More Information]
  • Simonneau, G., Gatzoulis, M., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Angel Gomez Sanchez, M., Kumar, R., Landzberg, M., Machado, R., et al (2013). Updated Clinical Classification of Pulmonary Hypertension. Journal of the American College of Cardiology, 62(25 Suppl D), D34-D41. [More Information]
  • Skilton, M., Marks, G., Ayer, J., Garden, F., Garnett, S., Harmer, J., Leeder, S., Toelle, B., Webb, K., Baur, L., Celermajer, D. (2013). Weight gain in infancy and vascular risk factors in later childhood. Pediatrics, 131(6), e1821-e1828. [More Information]
  • Lau, E., Iyer, N., Ilsar, R., Bailey, B., Adams, M., Celermajer, D. (2012). Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound. PLoS One, 7(3), 1-6. [More Information]
  • McGrath, K., Li, X., Gaus, K., Williams, P., Celermajer, D., Handelsman, D., Heather, A. (2012). Androgens Rapidly Activate Nuclear Factor-Kappa B via Intracellular Ca2 Signalling in Human Vascular Endothelial Cells. Journal of Steroids & Hormonal Science, S2, 1-6. [More Information]
  • Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J., Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R., Rajamani, K., et al (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment - The FIELD Study. Diabetes Care, 35(2), 218-225. [More Information]
  • Celermajer, D., Chow, C., Marijon, E., Anstey, N., Woo, K. (2012). Cardiovascular Disease in the Developing World: Prevalences, Patterns, and the Potential of Early Disease Detection. Journal of the American College of Cardiology, 60(14), 1207-1216. [More Information]
  • Skilton, M., Sullivan, T., Ayer, J., Harmer, J., Toelle, B., Webb, K., Marks, G., Celermajer, D. (2012). Carotid extra-medial thickness in childhood: Early life effects on the arterial adventitia. Atherosclerosis, 222(2), 478-482. [More Information]
  • Rose, M., Strange, G., King, I., Arnuop, S., Vidmar, S., O'Donnell, C., Kermeen, F., Grigg, L., Weintraub, R., Celermajer, D. (2012). Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry. Internal Medicine Journal, 42(8), 874-879. [More Information]
  • Dalton, B., McNeil, K., Keogh, A., Williams, T., Proudman, S., Gabbay, E., Kotlyar, E., Weintraub, R., Kermeen, F., Celermajer, D., et al (2012). Design and delivery of an e-learning curriculum for physicians involved in the management of pulmonary hypertension. International Journal of Clinical Practice, 66(11), 1117-1124. [More Information]
  • O'Meagher, S., Munoz, P., Alison, J., Young, I., Tanous, D., Celermajer, D., Puranik, R. (2012). Exercise capacity and stroke volume are preserved late after tetralogy repair, despite severe right ventricular dilatation. Heart, 98(21), 1595-1599. [More Information]
  • Talib, J., Pattison, D., Harmer, J., Celermajer, D., Davies, M. (2012). High plasma thiocyanate levels modulate protein damage induced by myeloperoxidase and perturb measurement of 3-chlorotyrosine. Free Radical Biology and Medicine, 53(1), 20-29. [More Information]
  • Skilton, M., Ayer, J., Harmer, J., Webb, K., Leeder, S., Marks, G., Celermajer, D. (2012). Impaired Fetal Growth and Arterial Wall Thickening: A Randomized Trial of Omega-3 Supplementation. Pediatrics, 129(3), e698-e703. [More Information]
  • Don, G., Joseph, F., Celermajer, D., Corte, T. (2012). Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan. Internal Medicine Journal, 42(12), 1351-1354. [More Information]
  • Zahnd, G., Vray, D., Serusclat, A., Alibay, D., Bartold, M., Brown, A., Durand, M., Jamieson, L., Kapellas, K., Maple-Brown, L., Celermajer, D., Skilton, M., et al (2012). Longitudinal displacement of the carotid wall and cardiovascular risk factors: associations with aging, adiposity, blood pressure and periodontal disease independent of cross-sectional distensibility and intima-media thickness. Ultrasound in Medicine and Biology, 38(10), 1705-1715. [More Information]
  • Morton, J., Zoungas, S., Li, Q., Patel, A., Chalmers, J., Woodward, M., Celermajer, D., Beulens, J., Stolk, R., Glasziou, P., Ng, M. (2012). Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study. Diabetes Care, 35(11), 2201-2206. [More Information]
  • Celermajer, D. (2012). Manipulating nature: Might there be a cardiovascular price to pay for the miracle of assisted conception? Circulation, 125(15), 1832-1834. [More Information]
  • Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Liew, D., Patterson, K., Hissaria, P., Roddy, J., Zochling, J., Celermajer, D., Youssef, P., et al (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research and Therapy, 14(3), 1-10. [More Information]
  • Marshall, N., Ayer, J., Toelle, B., Phillips, C., Grunstein, R., Celermajer, D., Marks, G. (2012). Parentally Reported Snoring Is Not Enough Information To Justify Treatment. Journal of Paediatrics and Child Health, 48(1), 78-78. [More Information]
  • Marijon, E., Mirabel, M., Celermajer, D., Jouven, X. (2012). Rheumatic heart disease. The Lancet, 379(9819), 953-964. [More Information]
  • Mirabel, M., Celermajer, D., Ferreira, B., Tafflet, M., Perier, M., Karam, N., Mocumbi, A., Jani, D., Sidi, D., Jouven, X., Marijon, E. (2012). Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach. European journal of Echocardiography, 13(12), 1024-1029. [More Information]
  • Golzan, S., Leaney, J., Cordina, R., Avolio, A., Celermajer, D., Graham, S. (2012). Spontaneous retinal venous pulsatility in patients with cyanotic congenital heart disease. Heart and Vessels: an international journal, 27(6), 618-623. [More Information]
  • Cordina, R., Celermajer, D., McGuire, M. (2012). Systemic venous anatomy in congenital heart disease: implications for electrophysiologic testing and catheter ablation. Journal of Interventional Cardiac Electrophysiology, 33(2), 143-149. [More Information]
  • Flammer, A., Anderson, T., Celermajer, D., Creager, M., Deanfield, J., Ganz, P., Hamburg, N., Luscher, T., Shechter, M., Taddei, S., et al (2012). The assessment of endothelial function: from research into clinical practice. Circulation, 126(6), 753-767. [More Information]
  • Rangan, A., Flood, V., Denyer, G., Ayer, J., Webb, K., Marks, G., Celermajer, D., Gill, T. (2012). The effect of dairy consumption on blood pressure in mid-childhood: CAPS cohort study. European Journal of Clinical Nutrition, 66(6), 652-657. [More Information]
  • Kwok, T., Chook, P., Qiao, M., Tam, L., Poon, Y., Ahuja, A., Woo, J., Celermajer, D., Woo, K. (2012). Vitamin B-12 supplementation improves arterial function in vegetarians with subnormal vitamin B-12 status. The Journal of Nutrition, Health and Aging, 16(6), 569-573. [More Information]
  • Levy, M., Celermajer, D., Bourges-Petit, E., Del Cerro, M., Bajolle, F., Bonnet, D. (2011). Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension. The Journal of Pediatrics, 158(4), 584-588. [More Information]
  • Davis, J., Darcy, C., Yeo, T., Jones, C., McNeil, Y., Stephens, D., Celermajer, D., Anstey, N. (2011). Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PLoS One, 6(2), e17260-1-e17260-6. [More Information]
  • Plichart, M., Celermajer, D., Zureik, M., Helmer, C., Jouven, X., Ritchie, K., Tzourio, C., Ducimetière, P., Empana, J. (2011). Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis, 219(2), 917-924. [More Information]
  • Lau, E., Manes, A., Celermajer, D., Galie, N. (2011). Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. European Heart Journal, 32(20), 2489-2498. [More Information]
  • Skilton, M., Viikari, J., Juonala, M., Laitinen, T., Lehtimaki, T., Taittonen, L., Kahonen, M., Celermajer, D., Raitakari, O. (2011). Fetal Growth and Preterm Birth Influence Cardiovascular Risk Factors and Arterial Health in Young Adults: The Cardiovascular Risk in Young Finns Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(12), 2975-2981. [More Information]
  • Jouven, X., Escolano, S., Celermajer, D., Empana, J., Bingham, A., Hermine, O., Desnos, M., Perier, M., Marijon, E., Ducimetiere, P. (2011). Heart rate and risk of cancer death in healthy men. PLoS One, 6(8), e21310 - 1-e21310 - 7. [More Information]
  • Morgan, P., Pattison, D., Talib, J., Summers, F., Harmer, J., Celermajer, D., Hawkins, C., Davies, M. (2011). High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase. Free Radical Biology and Medicine, 51(9), 1815-1822. [More Information]
  • Ng, A., Chung, T., Yong, A., Wong, H., Chow, V., Celermajer, D., Kritharides, L. (2011). Long-Term Cardiovascular and Noncardiovascular Mortality of 1023 Patients With Confirmed Acute Pulmonary Embolism. Circulation. Cardiovascular Quality and Outcomes, 4(1), 122-128. [More Information]
  • Ayer, J., Belousova, E., Harmer, J., Toelle, B., Celermajer, D., Marks, G. (2011). Lung Function Is Associated with Arterial Stiffness in Children. PLoS One, 6(10), e26303 - 1-e26303 - 4. [More Information]
  • Ayer, J., Belousova, E., Harmer, J., David, C., Marks, G., Celermajer, D. (2011). Maternal cigarette smoking is associated with reduced high-density lipoprotein cholesterol in healthy 8-year-old children. European Heart Journal, 32(19), 2446-2453. [More Information]
  • Roberts, P., Boudjemline, Y., Cheatham, J., Eicken, A., Ewert, P., McElhinney, D., Hill, S., Berger, F., Khan, D., Schranz, D., Celermajer, D., et al (2011). Percutaneous Tricuspid Valve Replacement in Congenital and Acquired Heart Disease. Journal of the American College of Cardiology, 58(2), 117-122. [More Information]
  • Ayer, J., Harmer, J., David, C., Steinbeck, K., Seale, J., Celermajer, D. (2011). Severe obesity is associated with impaired arterial smooth muscle function in young adults. Obesity, 19(1), 54-60.
  • Marshall, N., Ayer, J., Toelle, B., Harmer, J., Phillips, C., Grunstein, R., Celermajer, D., Marks, G. (2011). Snoring is not associated with adverse effects on blood pressure, arterial structure or function in 8-year-old children: The Childhood Asthma Prevention Study (CAPS). Journal of Paediatrics and Child Health, 47(8), 518-523. [More Information]
  • Marijon, E., Tafflet, M., Celermajer, D., Dumas, F., Perier, M., Mustafic, H., Toussaint, J., Desnos, M., Rieu, M., Benameur, N., et al (2011). Sports-related sudden death in the general population. Circulation, 124(6), 672-681. [More Information]
  • Skilton, M., Maple-Brown, L., Kapellas, K., Celermajer, D., Bartold, P., Brown, A., O'Dea, K., Slade, G., Jamieson, L. (2011). The effect of a periodontal intervention on cardiovascular risk markers in Indigenous Australians with periodontal disease: the PerioCardio study. BMC Public Health, 11(1), 729-1-729-8. [More Information]
  • Iyer, N., Lau, E., Ilsar, R., Celermajer, D. (2011). Treatment responsiveness in pulmonary arterial hypertension-Preliminary report on serial intra-arterial Doppler flow velocity waveform measurements. International Journal of Cardiology, 153(2), 219-221. [More Information]
  • Smadja, D., Mauge, L., Gaussem, P., d'Audigier, C., Israel-Biet, D., Celermajer, D., Bonnet, D., Levy, M. (2011). Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension. Angiogenesis, 14(1), 17-27. [More Information]
  • Changsirivathanathamrong, D., Wang, Y., Rajbhandari, D., Maghzal, G., Mak, W., Woolfe, C., Duflou, J., Gebski, V., Dos Remedios, C., Celermajer, D., Stocker, R. (2011). Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. Critical Care Medicine, 39(12), 2678-2683. [More Information]
  • Sieveking, D., Lim, P., Chow, R., Dunn, L., Bao, B., McGrath, K., Heather, A., Handelsman, D., Celermajer, D., Ng, M. (2010). A sex-specific role for androgens in angiogenesis. The Journal of Experimental Medicine, 207(2), 345-352. [More Information]
  • Davis, J., Yeo, T., Piera, K., Woodberry, T., Celermajer, D., Stephens, D., Anstey, N. (2010). Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Critical Care, 14: R89(3), 1-8. [More Information]
  • Patel, S., Di Bartolo, B., Nakhla, S., Heather, A., Mitchell, T., Jessup, W., Celermajer, D., Barter, P., Rye, K. (2010). Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Atherosclerosis, 212(2), 392-397. [More Information]
  • Ilsar, R., Levitt, J., Ng, M., Kritharides, L., Celermajer, D. (2010). Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension. The European Respiratory Journal, 36(6), 1483-1485. [More Information]
  • Ayer, J., Harmer, J., Marks, G., Avolio, A., Celermajer, D. (2010). Central arterial pulse wave augmentation is greater in girls than boys, independent of height. Journal of Hypertension, 28(2), 306-313.
  • Cordina, R., Celermajer, D. (2010). Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease. Cardiology in the Young, 20(3), 242-53. [More Information]
  • Puranik, R., Celermajer, D., Muthurangu, V., Taylor, A., Puranik, R. (2010). Congenital heart disease and multi-modality imaging. Heart, Lung and Circulation, 19(3), 133-144. [More Information]
  • Ilsar, R., Chawantanpipat, C., Chan, K., Dobbins, T., Waugh, R., Hennessy, A., Celermajer, D., Ng, M. (2010). Doppler-derived Pulmonary Flow Reserve Detects Pulmonary Microvascular Obstruction in High Primates. Heart, Lung and Circulation, 19(10), 592-594. [More Information]
  • Mackie, F., Rosenberg, A., Harmer, J., Kainer, G., Celermajer, D. (2010). HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD) - a pilot study. Acta Paediatrica: Nurturing the Child, 99(10.1111/j.1651-2227.2009.01643.x), 457-459. [More Information]
  • Yeo, T., Lampah, D., Tjitra, E., Gitawati, R., Darcy, C., Jones, C., Kenangalem, E., McNeil, Y., Granger, D., Lopansri, B., Celermajer, D., et al (2010). Increased Asymmetric Dimethylarginine in Severe Falciparum Malaria: Association with Impaired Nitric Oxide Bioavailability and Fatal Outcome. P L o S Pathogens, 6(4), e1000868-1-e1000868-8. [More Information]
  • Ayer, J., Song, C., Steinbeck, K., Celermajer, D., Freedman, B. (2010). Increased Tissue Factor Activity in Monocytes from Obese Young Adults. Clinical and Experimental Pharmacology and Physiology, 37(11), 1049-1054. [More Information]
  • Wang, Y., Liu, H., McKenzie, G., Witting, P., Stasch, J., Hahn, M., Changsirivathanathamrong, D., Wu, B., Ball, H., Thomas, S., Celermajer, D., Hunt, N., Stocker, R., et al (2010). Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nature Medicine, 16(3), 279-285. [More Information]
  • Cordina, R., Celermajer, D. (2010). Late-Onset Pulmonary Arterial Hypertension After a Successful Atrial or Arterial Switch Procedure for Transposition of the Great Arteries. Pediatric Cardiology, 31(10.1007/s00246-009-9597-9), 238-241. [More Information]
  • Ayer, J., Sholler, G., Celermajer, D. (2010). Left atrial size increases with body mass index in children. International Journal of Cardiology, 141(1), 61-67. [More Information]
  • Ilsar, R., Chawantanpipat, C., Chan, K., Dobbins, T., Waugh, R., Hennessy, A., Celermajer, D., Ng, M. (2010). Measurement of pulmonary flow reserve and pulmonary index of microcirculatory resistance for detection of pulmonary microvascular obstruction. PLoS One, 5(3), e9601 - 1-e9601 - 9. [More Information]
  • Lau, E., Yee, B., Grunstein, R., Celermajer, D. (2010). Patent foramen ovale and obstructive sleep apnea: A new association? Sleep Medicine Reviews, 14(6), 391-395. [More Information]
  • Roberts, P., Spina, R., Vallely, M., Wilson, M., Bailey, B., Celermajer, D. (2010). Percutaneous tricuspid valve replacement for a stenosed bioprosthesis. Circulation. Cardiovascular Interventions, 3(4), e14-e15. [More Information]
  • Ban, C., Twigg, S., Franjic, B., Brooks, B., Celermajer, D., Yue, D., McLennan, S. (2010). Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction. Diabetes Research and Clinical Practice, 87(3), 335-341. [More Information]
  • Ayer, J., Harmer, J., David, C., Steinbeck, K., Seale, J., Celermajer, D. (2010). Severe Obesity Is Associated With Impaired Arterial Smooth Muscle Function in Young Adults. Obesity, 19(1), 54-60. [More Information]
  • Ilsar, R., Bailey, B., Dobbins, T., Celermajer, D. (2010). The Relationship Between Pulmonary Artery and Pulmonary Capillary Wedge Pressure for the Diagnosis of Pulmonary Vascular Disease. Heart, Lung and Circulation, 19(1), 38-42. [More Information]
  • Patel, S., Chung, S., White, G., Bao, B., Celermajer, D. (2010). The “atheroprotective�? mediators apolipoproteinA-I and Foxp3 are over-abundant in unstable carotid plaques. International Journal of Cardiology, 145(2), 183-187. [More Information]
  • Cordina, R., Celermajer, D. (2010). Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension. European respiratory review : an official journal of the European Respiratory Society, 19(118), 300-307. [More Information]
  • Patel, S., Puranik, R., Nakhla, S., Lundmand, P., Stocker, R., Wang, X., Lambert, G., Rye, K., Barter, P., Nicholls, S., Celermajer, D. (2009). Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis, 204(2), 424-428. [More Information]
  • Ayer, J., Harmer, J., Xuan, W., Toelle, B., Webb, K., Almqvist, C., Marks, G., Celermajer, D. (2009). Dietary supplementation with n-3 polyunsaturated fatty acids in early childhood: Effects on blood pressure and arterial structure and function at age 8 y1–3. American Journal of Clinical Nutrition, 90, 438-446. [More Information]
  • Ayer, J., Harmer, J., Nakhla, S., Xuan, W., Ng, M., Raitakari, O., Marks, G., Celermajer, D. (2009). HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(6), 943-949. [More Information]
  • Ilsar, R., Chawantanpipat, C., Chan, K., Waugh, R., Hennessy, A., Celermajer, D., Ng, M. (2009). Measurement of pulmonary flow reserve in higher primates. Clinical and Experimental Pharmacology and Physiology, 36(8), 797-802. [More Information]
  • Ayer, J., Harmer, J., Steinbeck, K., Celermajer, D. (2009). Postprandial Vascular Reactivity in Obese and Normal Weight Young Adults. Obesity, Online(10.1038/oby.2009.331), 1-7. [More Information]
  • Chow, C., Joshi, R., Celermajer, D., Patel, A., Neal, B. (2009). Recalibration of a Framingham risk equation for a rural population in India. Journal of Epidemiology and Community Health, 63(5), 379-385. [More Information]
  • Patel, S., Drew, B., Nakhla, S., Duffy, S., Murphy, A., Barter, P., Rye, K., Chin-Dusting, J., Hoang, A., Sviridov, D., Celermajer, D., et al (2009). Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. Journal of the American College of Cardiology, 53(11), 962-971. [More Information]
  • Celermajer, D. (2009). Wait for weight or waste" the waist the benefits of early intervention in childhood obesity.". Journal of the American College of Cardiology, 54(25), 2407-2408. [More Information]
  • Agnoletti, G., Ou, P., Celermajer, D., Boudjemline, Y., Marini, D., Bonnet, D., Aggoun, Y. (2008). Acute angulation of the aortic arch predisposes a patient to ascending aortic dilatation and aortic regurgitation late after the arterial switch operation for transposition of the great arteries. The Journal of Thoracic and Cardiovascular Surgery, 135(3), 568-572. [More Information]
  • Yeo, T., Lampahc, D., Gitawatie, R., Tjitra, E., Kenangalem, E., Piera, K., Price, R., Duffull, S., Celermajer, D., Anstey, N. (2008). Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 105(44), 17097-17102. [More Information]
  • Ou, P., Celermajer, D., Raisky, O., Jolivet, O., Buyens, F., Herment, A., Sidi, D., Bonnet, D., Mousseaux, E. (2008). Angular (Gothic) aortic arch leads to enhanced systolic wave reflection, central aortic stiffness, and increased left ventricular mass late after aortic coarctation repair: evaluation with magnetic resonance flow mapping. The Journal of Thoracic and Cardiovascular Surgery, 135(1), 62-68. [More Information]
  • Patel, S., Celermajer, D., Bao, B. (2008). Atherosclerosis - Underlying inflammatory mechanisms and clinical implications. The International Journal of Biochemistry and Cell Biology, 40(4), 576-580. [More Information]
  • Ayer, J., Almafragy, H., Patel, A., Hellyer, R., Celermajer, D. (2008). Body mass index is an independent determinant of left atrial size. Heart, Lung and Circulation, 17(1), 19-24. [More Information]
  • McGrady, M., Thanyasiri, P., Bailey, B., Celermajer, D., Adams, M. (2008). Determinants of coronary arterial flow-mediated dilatation following percutaneous coronary intervention. Catheterization and Cardiovascular Interventions, 71(3), 327-332. [More Information]
  • Chow, C., McQuillan, B., Raju, P., Iyengar, S., Raju, R., Harmer, J., Neal, B., Celermajer, D. (2008). Greater adverse effects of cholesterol and diabetes on carotid intima-media thickness in South Asian Indians: Comparison of risk factor-IMT associations in two population-based surveys. Atherosclerosis, 199(1), 116-122. [More Information]
  • Ou, P., Celermajer, D., Jolivet, O., Buyens, F., Herment, A., Sidi, D., Bonnet, D., Mousseaux, E. (2008). Increased central aortic stiffness and left ventricular mass in normotensive young subjects after successful coarctation repair. American Heart Journal, 155(1), 187-193. [More Information]
  • Puranik, R., Bao, B., Nobecourt, E., Nicholls, S., Dusting, G., Barter, P., Celermajer, D., Rye, K. (2008). Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis, 196(1), 240-247. [More Information]
  • Yeo, T., Lampah, D., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y., Darcy, C., Granger, D., Weinberg, J., et al, Celermajer, D. (2008). Recovery of Endothelial Function in Severe Falciparum Malaria: Relationship with Improvement in Plasma l-Arginine and Blood Lactate Concentrations. The Journal of Infectious Diseases, 198(4), 602-608. [More Information]
  • Kilian, J., Thanyasiri, P., Celermajer, D., Adams, M. (2008). Saphenous Vein Grafts Display Poor Endothelium-Dependent and Endothelium-Independent Dilation - Implications for the Pathogenesis of Vein Graft Atherosclerosis. Heart, Lung and Circulation, 17(2), 96-99. [More Information]
  • Chow, C., Naidu, S., Raju, P., Raju, R., Joshi, R., Sullivan, D., Celermajer, D., Neal, B. (2008). Significant lipid, adiposity and metabolic abnormalities amongst 4535 Indians from a developing region of rural Andhra Pradesh. Atherosclerosis, 196, 943-952. [More Information]
  • Thomas, G., Chook, P., Yip, T., Kwong, S., Chan, T., Qiao, M., Huang, X., Guo, D., Feng, J., Chan, S., Celermajer, D., et al (2008). Smoking without exception adversely affects vascular structure and function in apparently healthy Chinese: implications in global atherosclerosis prevention. International Journal of Cardiology, 128(2), 172-177. [More Information]
  • Sieveking, D., Buckle, A., Celermajer, D., Ng, M. (2008). Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. Journal of the American College of Cardiology, 51(6), 660-668. [More Information]
  • Lattimore, J., Wilcox, I., Adams, M., Kilian, J., Celermajer, D. (2008). Treatment of obstructive sleep apnoea leads to enhanced pulmonary vascular nitric oxide release. International Journal of Cardiology, 126, 229-233. [More Information]
  • Celermajer, D., Ng, M. (2008). Where there's smoke.. Journal of the American College of Cardiology, 51(18), 1772-4. [More Information]
  • Puranik, R., Greaves, K., Hawker, R., Pressley, L., Robinson, P., Celermajer, D. (2007). Abnormal Right Ventricular Tissue Velocities After Repair of Congenital Heart Disease-Implications for Late Outcomes. Heart, Lung and Circulation, 16(4), 295-299. [More Information]
  • Patel, S., Drew, B., Duffy, S., Nahkla, S., Rye, K., Barter, P., Celermajer, D., Kingwell, B. (2007). Abstract 1047: Infusion of Reconstituted High Density Lipoproteins Into Humans Enhances the In Vitro Anti-Inflammatory Capacity of the High Density Lipoprotein Fraction. Circulation, 116, II_209.
  • Chandrasegaram, M., Celermajer, D., Wilson, M. (2007). Apical ballooning syndrome complicated by acute severe mitral regurgitation with left ventricular outflow obstruction – Case report. Journal of Cardiothoracic Surgery, 2(14), 1-14. [More Information]
  • Chow, C., Cardona-Morrell, M., Raju, P., Iyengar, S., Sukumar, A., Raju, C., Colman, S., Madhav, P., Raju, R., Reddy, K., Celermajer, D., Neal, B. (2007). Cardiovascular disease and risk factors among 345 adults in rural India-the Andhra Pradesh Rural Health Initiative. International Journal of Cardiology, 116(2), 180-185. [More Information]
  • Patel, S., Harmer, J., Loughnan, G., Skilton, M., Steinbeck, K., Celermajer, D. (2007). Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. Clinical Endocrinology, 66(6), 771-777. [More Information]
  • Marijon, E., Trinquart, L., Jani, D., Jourdier, H., Garbarz, E., Mocumbi, A., Celermajer, D., Ferreira, B. (2007). Coronary heart disease and associated risk factors in sub-Saharan Africans. Journal of Human Hypertension, 21(5), 411-414.
  • Ou, P., Celermajer, D., Agnoletti, G., Brunelle, F., Vouhe, P., Sidi, D., Bonnet, D. (2007). Definitive diagnosis of pulmonary artery sling in a critically ill infant with high resolution computed tomography. Circulation, 115, e398-e399.
  • Brooks, B., Franjic, B., Ban, C., Swaraj, K., Yue, D., Celermajer, D., Twigg, S. (2007). Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes, Obesity and Metabolism, online publication(doi: 10.1111/j.1463-1326.2007.00803.x), 1-8. [More Information]
  • Celermajer, D., Marwick, T. (2007). Echocardiographic and right heart catheterization techniques in patients with pulmonary arterial hypertension. International Journal of Cardiology, 125, 294-303. [More Information]
  • Levy, M., Maurey, C., Celermajer, D., Vouhe, P., Danel, C., Bonnet, D., Israel-Biet, D. (2007). Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. Journal of the American College of Cardiology, 49(7), 803-810. [More Information]
  • Yeo, T., Lampah, D., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y., Darcy, C., Granger, D., Weinberg, J., Lopansri, B., Celermajer, D., et al (2007). Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria. The Journal of Experimental Medicine, 204(11), 2693-2704.
  • Maple-Brown, L., Piers, L., O'Rourke, M., Celermajer, D., O'Dea, K. (2007). Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease. Journal of Hypertension, 25(3), 585-591. [More Information]
  • Maple-Brown, L., Cunningham, J., Celermajer, D., O'Dea, K. (2007). Increased carotid intima-media thickness in remote and urban Indigenous Australians: impact of diabetes and components of the metabolic syndrome. Clinical Endocrinology, 66(3), 419-425. [More Information]
  • Marijon, E., Ou, P., Celermajer, D., Ferreira, B., Mocumbi, A., Jani, D., Paquet, C., Jacob, S., Sidi, D., Jouven, X. (2007). Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening. New England Journal of Medicine, 357(5), 470-476.
  • Celermajer, D. (2007). Protecting children from passive smoking. Circulation (Baltimore), 115, 3143-3144. [More Information]
  • Proudman, S., Stevens, W., Sahhar, J., Celermajer, D. (2007). Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Internal Medicine Journal, 37(7), 485-494.
  • Webb, R., Wilson, N., Lennon, D., Marijon, E., Celermajer, D., Jouven, X. (2007). Rheumatic Heart Disease Detected by Echocardiographic Screening. The New England Journal of Medicine, 357(20), 2088-2089. [More Information]
  • Skilton, M., Sieveking, D., Harmer, J., Franklin, J., Loughnan, G., Nakhla, S., Sullivan, D., Caterson, I., Celermajer, D. (2007). The effects of obesity and non-pharmacological weight loss on vascular and ventricular function and structure. Diabetes, Obesity and Metabolism, 10(10), 874-884. [More Information]
  • Brand-Miller, J., Dickinson, S., Barclay, A., Celermajer, D. (2007). The glycemic index and cardiovascular disease risk. Current atherosclerosis reports, 9(6), 479-85. [More Information]
  • Ou, P., Celermajer, D., Mousseux, E., Giron, A., Aggoun, Y., Szezepanski, I., Sidi, D., Bonnet, D. (2007). Vascular remodelling after "successful" repair of coarctation: impact of aortic arch geometry. Journal of the American College of Cardiology, 49(8), 883-890. [More Information]
  • Puranik, R., Bao, B., Celermajer, D., Rye, K., Barter, P., Nicholls, S., Nobecourt, E. (2006). A single infusion of lipid free apo A1 can rescue vascular inflammation. Atherosclerosis Supplements, 7, 153.
  • Puranik, R., Nobecourt, E., Bao, B., Davies, M., Barter, P., Celermajer, D., Rye, K. (2006). Abstract 1355: The Impact of Glycation on the Anti-inflammatory Properties of High Density Lipoproteins in vivo. Circulation, 114, II-257-II-258.
  • Ou, P., Mousseaux, E., Celermajer, D., Pedroni, E., Vouhe, P., Sidi, D., Bonnet, D. (2006). Aortic arch shape deformation after coarctation surgery: effect on blood pressure response. The Journal of Thoracic and Cardiovascular Surgery, 132(5), 1105-1111. [More Information]
  • Patel, S., Celermajer, D. (2006). Assessment of vascular disease using arterial flow mediated dilatation. Pharmacological Reports, 58, 3-7. [More Information]
  • Kotlyar, E., Sy, R., Keogh, A., Kermeen, F., Macdonald, P., Hayward, C., McNeil, K., Celermajer, D. (2006). Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease. Cardiology in the Young, 16(3), 268-274. [More Information]
  • Celermajer, D., Ayer, J. (2006). Childhood risk factors for adult cardiovascular disease and primary prevention in childhood. Heart, 92(11), 1701-1706. [More Information]
  • Nicholls, S., Lundman, P., Harmer, J., Cutri, B., Griffiths, K., Rye, K., Barter, P., Celermajer, D. (2006). Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. Journal of the American College of Cardiology, 48(4), 715-720. [More Information]
  • Skilton, M., Celermajer, D. (2006). Endothelial dysfunction and arterial abnormalities in childhood obesity. International Journal of Obesity, 30(7), 1041-1049. [More Information]
  • Thanyasiri, P., Kathir, K., Celermajer, D., Adams, M. (2006). Endothelial dysfunction and restenosis following percutaneous coronary intervention. International Journal of Cardiology, , 1-6. [More Information]
  • Lau, A., Chaufour, X., McLachlan, C., Leichtweis, S., Celermajer, D., Sullivan, C., Stocker, R. (2006). Intimal thickening after arterial balloon injury is increased by intermittent repetitive hypoxia, but intermittent repetitive hyperoxia is not protective. Atherosclerosis, 185(2), 254-263. [More Information]
  • Skilton, M., Gosby, A., Wu, B., Ho, L., Stocker, R., Caterson, I., Celermajer, D. (2006). Maternal undernutrition reduces aortic wall thickness and elastin content in offspring rats without altering endothelial function. Clinical Science, 111(4), 281-287. [More Information]
  • Thanyasiri, P., Celermajer, D., Adams, M. (2006). Predictors of long-term outcome following percutaneous coronary intervention in patients with type 2 diabetes mellitus. Coronary Artery Disease, 17(2), 131-138. [More Information]
  • Tanous, D., Brasen, J., Choy, K., Wu, B., Kathir, K., Lau, A., Celermajer, D., Stocker, R. (2006). Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis, 189(2), 342-349. [More Information]
  • Skilton, M., Celermajer, D. (2006). The effects of obesity-related peptides on the vasculature. Current Vascular Pharmacology, 4(1), 79-85. [More Information]
  • Chow, C., Raju, P., Raju, K., Reddy, K., Cardona-Morrell, M., Celermajer, D., Neal, B. (2006). The prevalence and management of diabetes in rural Indian Adults. (Letter). Diabetes Care, 29(7), 1717-1718. [More Information]
  • Ou, P., Celermajer, D., Calcagni, G., Brunelle, F., Bonnet, D., Sidi, D. (2006). Three-Dimensional CT Scanning: A Novel Diagnostic Modality in Congenital Heart Disease. Heart, 93(8), 908-913. [More Information]
  • Lattimore, J., Wilcox, I., Skilton, M., Langenfeld, M., Celermajer, D. (2006). Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax, 61(6), 491-495. [More Information]
  • Kilian, J., Nakhla, S., Sieveking, D., Celermajer, D. (2005). Adenosine prevents neutrophil adhesion to human endothelial cells after hypoxia/reoxygenation. International Journal of Cardiology, 105(3), 322-326. [More Information]
  • Sader, M., McGrath, K., Hill, M., Bradstock, K., Jimenez, M., Handelsman, D., Celermajer, D., Heather, A. (2005). Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis. Clinical Endocrinology, 62(1), 56-63. [More Information]
  • Skilton, M., Evans, N., Griffiths, K., Harmer, J., Celermajer, D. (2005). Aortic wall thickness in newborns with intrauterine growth restriction. The Lancet, 365(9469), 1484-1486. [More Information]
  • Joshua, A., Celermajer, D., Stockler, M. (2005). Beauty is in the eye of the examiner: reaching agreement about physical signs and their value. Internal Medicine Journal, 35(3), 178-187. [More Information]
  • Celermajer, D. (2005). Brachial artery FMD with 5-minute distal cuff occlusion--a useful pathophysiological test after all!. Journal of Applied Physiology, 99(4), 1619. [More Information]
  • Maple-Brown, L., O'Rourke, M., Piers, L., Celermajer, D., O'Dea, K. (2005). Central obesity is associated with reduced peripheral wave reflection in Indigenous Australians irrespective of diabetes status. Journal of Hypertension, 23(7), 1403-1407. [More Information]
  • Chow, C., Amos, D., Celermajer, D. (2005). Cerebrovascular events in young adults after surgical repair of tetralogy of Fallot. Cardiology in the Young, 15(2), 130-132. [More Information]
  • Sieveking, D., Woo, K., Fung, K., Lundman, P., Nakhla, S., Celermajer, D. (2005). Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. International Journal of Cardiology, 105(1), 40-45. [More Information]
  • Nicholls, S., Celermajer, D., Rye, K., Barter, P., Griffiths, K., Cutri, B., Harmer, J., Lundman, P. (2005). Consumption of saturated fat impairs endothelial function and the antiinflammatory properties of high-density lipoproteins. Circulation, 112(17), U43.
  • Thanyasiri, P., Celermajer, D., Adams, M. (2005). Endothelial dysfunction occurs in peripheral circulation in patients with acute and stable coronary artery disease. American Journal of Physiology: Heart and Circulatory Physiology, 289(2), H513-H517. [More Information]
  • Skilton, M., Lai, N., Griffiths, K., Molyneaux, L., Yue, D., Sullivan, D., Celermajer, D. (2005). Meal-related increases in vascular reactivity are impaired in older and diabetic adults: insights into roles of aging and insulin in vascular flow. American Journal of Physiology: Heart and Circulatory Physiology, 288(3), H1404-H1410. [More Information]
  • Lundman, P., Keech, A., Griffiths, K., Pillai, A., Celermajer, D. (2005). New carotid plaque formation is very common in adult patients with Type 2 diabetes mellitus. Diabetic Medicine, 22(3), 355-356. [More Information]
  • Skilton, M., Nakhla, S., Sieveking, D., Caterson, I., Celermajer, D. (2005). Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clinical and Experimental Pharmacology and Physiology, 32(10), 839-844. [More Information]
  • Celermajer, D. (2005). Primary and a half prevention: can we identify asymptomatic subjects with high vascular risk? (Editorial Comment). Journal of the American College of Cardiology, 45(12), 1994-1996. [More Information]
  • Sheil, M., Luxford, C., Davies, M., Peat, J., Nunn, G., Celermajer, D. (2005). Protein oxidation injury occurs during pediatric cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery, 130(4), 1054-1061. [More Information]
  • Kilian, J., Nakhla, S., Griffith, K., Harmer, J., Skilton, M., Celermajer, D. (2005). Reperfusion injury in the human forearm is mild and not attenuated by short-term ischaemic preconditioning. Clinical and Experimental Pharmacology and Physiology, 32(01-Feb), 86-90. [More Information]
  • Lattimore, J., Wilcox, I., Nakhla, S., Langenfeld, M., Jessup, W., Celermajer, D. (2005). Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. Atherosclerosis, 179(2), 255-259. [More Information]
  • Kilian, J., Celermajer, D., Adams, M. (2005). Safety of coronary angioplasty to chronic total occlusions. International Journal of Cardiology, 103(3), 256-258. [More Information]
  • Chow, C., Mou, D., Patel, A., Celermajer, D. (2005). The role of the 12-lead ECG as a screening test for cardiac source of embolus. Heart, Lung and Circulation, 14(4), 242-244. [More Information]
  • Keech, A., Grieve, S., Patel, A., Griffiths, K., Skilton, M., Watts, G., Marwick, T., Groshens, M., Celermajer, D. (2005). Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy. Diabetic Medicine, 22(11), 1558-1565. [More Information]
  • Kwok, T., Chook, P., Tam, L., Qiao, M., Woo, J., Celermajer, D., Woo, K. (2005). Vascular dysfunction in Chinese vegetarians: an apparent paradox? Journal of the American College of Cardiology, 46(10), 1957-1958. [More Information]
  • Thomas, G., Chook, P., Qiao, M., Huang, X., Leong, H., Celermajer, D., Woo, K. (2004). Deleterious Impact Of "High Normal" Glucose Levels And Other Metabolic Syndrome Components On Arterial Endothelial Function And Intima-Media Thickness In Apparently Healthy Chinese Subjects: The CATHAY Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(4), 739-743.
  • Heather, A., McGrath, K., Sader, M., Nakhla, S., Jessup, W., Handelsman, D., Celermajer, D. (2004). Dihydrotestosterone Promotes Vascular Cell Adhesion Molecule-1 Expression In Male Human Endothelial Cells Via A Nuclear Factor-κB-Dependent Pathway. Endocrinology, 145(4), 1889-1897.
  • Woo, K., Chook, P., Yu, C., Sung, R., Qiao, M., Leung, S., Lam, C., Metreweli, C., Celermajer, D. (2004). Effects Of Diet And Exercise On Obesity-Related Vascular Dysfunction In Children. Circulation, 109(16), 1981-1986.
  • Woodman, R., Celermajer, D., Thompson, P., Hung, J. (2004). Folic Acid Does Not Improve Endothelial Function In Healthy Hyperhomocysteinaemic Subjects. Clinical Science, 106(4), 353-358.
  • Ng, M., Celermajer, D. (2004). Glucocorticoid treatment and cardiovascular disease. Heart, 90(Aug.), 829-830.
  • Skilton, M., Ho, L., Gosby, A., Caterson, I., Celermajer, D. (2004). Maternal Undernutrition And Early Postnatal Diet Affect Aortic Structure And Composition In Rats. Journal of the American College of Cardiology, 43 Abstracts(5), 517A-517A.
  • Celermajer, D., Greaves, K., Puranik, R., O'Leary, J. (2004). Myocardial Tissue Velocities In The Normal Left And Right Ventricles: Relationships And Predictors. Heart, Lung and Circulation, 13(4), 367-373.
  • Woo, K., Chook, P., Yu, C., Sung, R., Leung, S., Qiao, M., Lam, C., Metreweli, C., Celermajer, D. (2004). Overweight In Children Is Associated With Arterial Endothelial Dysfunction And Intima-Media Thickening. International Journal of Obesity, 28(7), 852-857.
  • Sullivan, D., Celermajer, D., Le Couteur, D., Lam, C. (2004). The Vascular Implications Of Postprandial Lipoprotein Metabolism. Clinical Biochemist Reviews, 25(1), 19-30.
  • Ng, M., Quinn, C., McCrohon, J., Nakhla, S., Jessup, W., Handelsman, D., Celermajer, D., Heather, A. (2003). Androgens Up-Regulate Atherosclerosis-Related Genes in Macrophages From Males But Not Females: Molecular Insights Into Gender Differences in Atherosclerosis. Journal of the American College of Cardiology, 42(7), 1306-1313. [More Information]
  • Greaves, K., Mou, D., Patel, A., Celermajer, D. (2003). Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart, 89(3), 273-275.
  • Celermajer, D. (2003). Clinical Trials: Evidence and Unanswered Questions Hypertension. Cerebrovascular Diseases, 16(Suppl. 3), 18-24.
  • Sheil, M., Cartmill, T., Nunn, G., Sholler, G., Raitakari, O., Celermajer, D. (2003). Contrast echocardiography: potential for the in-vivo study of pediatric myocardial preservation. The Annals of Thoracic Surgery, 75(5), 1542-1549.
  • Ng, M., Nakhla, S., Baoutina, A., Jessup, W., Handelsman, D., Celermajer, D. (2003). Dehydroepiandrosterone, an adrenal androgen, increases human foam cell formation. Journal of the American College of Cardiology, 42(11), 1967-1974. [More Information]
  • Liu, P., Wishart, S., Celermajer, D., Jimenez, M., Di Pierro, I., Conway, A., Handelsman, D. (2003). Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomised, placebo-controlled clinical trial of recombinant human chorionic gonadotropin. European Journal of Endocrinology, 148(1), 55-56.
  • Griffiths, K., Sader, M., Skilton, M., Harmer, J., Celermajer, D. (2003). Effects of Raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease. Journal of the American College of Cardiology, 42(4), 698-704.
  • Langenfeld, M., Simmons, L., McCrohon, J., Raitakari, O., Lattimore, J., Hennessy, A., Celermajer, D. (2003). Nitric Oxide does not Mediate the Vasodilation of Early Human Pregnancy. Heart, Lung and Circulation, 12(3), 142-148.
  • Lattimore, J., Celermajer, D., Wilcox, I. (2003). Obstructive sleep apnea and cardiovascular disease. Journal of the American College of Cardiology, 41(9), 1429-1437.
  • Sader, M., Griffiths, K., Skilton, M., Wishart, S., Handelsman, D., Celermajer, D. (2003). Physiological testosterone replacement and arterial endothelial function in men. Clinical Endocrinology, 59(1), 62-67.
  • Greaves, K., Bye, P., Parker, G., Celermajer, D. (2003). Prevalence of haemoptysis in adults with pulmonary atresia and ventricular septal defect, and the role of mammary artery collateral vessels. Heart, 89(8), 937-938.
  • Lau, A., Leichtweis, S., Hume, P., Mashima, R., Hou, J., Chaufour, X., Wilkinson, B., Hunt, N., Celermajer, D., Stocker, R. (2003). Probucol promotes functional reedothelialization in balloon-injured rabbit aortas. Circulation, 107(15), 2031-2036.
  • Puranik, R., Celermajer, D. (2003). Smoking and Endothelial Function. Progress In Cardiovascular Diseases, 45(6), 443-458.
  • Celermajer, D. (2003). Statins, skin, and the search for a test of endothelial function. Journal of the American College of Cardiology, 42(1), 78-80.
  • Kilian, J., Keech, A., Adams, M., Celermajer, D. (2002). Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coronary Artery Disease, 13(3), 155-159.
  • Sader, M., Celermajer, D. (2002). Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovascular Research, 53, 597-604.
  • Freedman, B., Brieger, D., Celermajer, D., Chalmers, J., Tofler, G., Campbell, T., Feneley, M., Marwick, T., Muller, D., Tonkin, A. (2002). Global cardiology comes to Australia: 14th World Congress of Cardiology, Sydney, 5-9 May 2002. Medical Journal of Australia, , 473-475.
  • Corretti, M., Anderson, T., Benjamin, E., Celermajer, D., Charbonneau, F., Creager, M., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., et al (2002). Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International brachial Artery Reactivity Task Force. Journal of the American College of Cardiology, 39(2), 257-265.
  • Woo, K., Chook, P., Chan, L., Cheung, A., Fung, W., Qiao, M., Lolin, Y., Thomas, G., Sanderson, J., Metreweli, C., Celermajer, D. (2002). Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplmentation. The American Journal of Medicine, 112(7), 535-539.
  • Sader, M., Miller, L., Caine, D., McCredie, R., Corr, M., Robertson, M., Watson, J., Celermajer, D. (2002). Neuropsychological and psychiatric outcomes following coronary surgery or angioplasty: a comparative study. Heart, Lung and Circulation, 11(2), 95-101.
  • Heather, A., Nakhla, S., McGrath, K., Martell, S., Yue, D., Celermajer, D., Jessup, W. (2002). Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages. Journal of the American College of Cardiology, 39(12), 1943-1950.
  • Wilson, S., Best, P., Edwards, W., Holmes, D., Carlson, P., Celermajer, D., Lermin, A. (2002). Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis, 160(1), 147-153.
  • Dzau, V., Bernstein, K., Celermajer, D., Cohen, J., Dahlof, B., Deanfield, J., Diez, J., Drexler, H., Ferrari, R., van Gilst, W., et al (2002). Pathophysiologic and therapeutic importance of tissue ACE. Cardiovascular Drugs and Therapy, 16(2), 149-160.
  • Ng, M., Liu, P., Williams, A., Nakhla, S., Ly, L., Handelsman, D., Celermajer, D. (2002). Prospective study of effect of androgens on serum inflammatory markers in men. Arteriosclerosis, Thrombosis, and Vascular Biology, 22(7), 1136-1141.
  • Celermajer, D., Greaves, K. (2002). Survivors of coarctation repair: fixed but not cured. Heart, 88, 113-114.
  • Celermajer, D. (2002). Understanding the pathophysiology of the arterial wall: which method should we choose? European Heart Journal, 4(September), F24-F28.
  • Ly, L., Zhuang, T., Celermajer, D., Handelsman, D., Jimenez, M., Conway, A. (2001). A double-blind, placebo-controlled, randomised clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. Journal of Clinical Endocrinology and Metabolism, 86, 4078-4088.
  • Sader, M., Griffiths, K., Handelsman, D., Celermajer, D., McCredie, R. (2001). Androgenic anabolic steroids and arterial structure and function in male body builders. Journal of the American College of Cardiology, 37, 224-230.
  • Premawardhana, U., Adams, M., Yue, D., Celermajer, D., Birrell, A. (2001). Cardiovascular structure and function in baboons with Type 1 diabetes - a transvenous ultrasound study. Journal of Diabetes and Its Complications, 15, 174-180.
  • Langenfeld, M., Nakhla, S., Death, A., Jessup, W., Celermajer, D. (2001). Endothelin-1 and oxidized low density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cells. Clinical Science, 101, 731-738.
  • Heather, A., Jessup, W., Celermajer, D., Langdenfeld, M., Nakhla, S. (2001). Endothelin-1 plus oxidized low-density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cells. Clinical Science, 101, 731-738.
  • Celermajer, D. (2001). Evidence-based medicine: how good is the evidence? Medical Journal of Australia, 174, 293-295.
  • Seale, J., Celermajer, D., Raitakari, O. (2001). Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. The American Journal of Cardiology, 87, 217-219.
  • Celermajer, D., Jarvisalo, M., Jartti, L., Nanto-Salonen,, K., Irjala, K., Ronnemaa, T., Hartiala, J., Raitakari, O. (2001). Increased aortic intime-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation, 104, 2943-2947.
  • Sader, M., Griffiths, K., Handelsman, D., Celermajer, D., McCredie, R., Wishart, S. (2001). Oestradiol improves arterial endothelial function in health men receiving testosterone. Clinical Endocrinology, 54, 175-181.
  • Sader, M., McCredie, R., Griffiths, K., Wishart, S., Handelsman, D., Celermajer, D. (2001). Oestradiol improves arterial endothelial function in healthy men receiving testosterone. Journal of the American College of Cardiology, 54, 175-181.
  • Ng, M., Jessup, W., Celermajer, D. (2001). Sex-related differences in the regulation of macrophage cholesterol metabolism. Current Opinion in Lipidology, 12, 506-510.
  • Celermajer, D., Woo, J., Woo, K., Leung,, S., Chook, P., Liu,, B., Ip,, R., Ho, S., Chan, S., Feng, J. (2001). The Mediterranean score of dietary habits in Chinese populations in four different geographical areas. European Journal of Clinical Nutrition, 55, 215-220.
  • Dzau, V., Bernstein, M., Celermajer, D. (2001). The Relevance of tissue ACE: manifestations in mechanistic and endpoint data. The American Journal of Cardiology, 88, 1-20.
  • Woo, K., Chook, P., Chan, W., So, W., Cockram, C., Celermajer, D. (2001). Type I diabetes and arterial dysfunction in asymptomatic Chinese adults. Diabetes Care, 24, 173.
  • Premawardhana, U., Celermajer, D. (2000). Advances in echocardiography. Internal Medicine Journal, 30, 360-366.
  • McCrohon, J., Death, A., Nakhla, S., Jessup, W., Handelsman, D., Stanley, K., Celermajer, D. (2000). Androgen receptor expression is greater in macrophages from male than from female donors. Circulation, 101, 224-226.
  • Raitakari, O., McCredie, R., Letters, J., Witting, P., Griffiths, K., Sullivan, D., Stocker, R., Celermajer, D. (2000). Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults. Free Radical Biology and Medicine, 28, 1100-1105.
  • McCrohon, J., Woo, K., Celermajer, D. (2000). Comparison of endothelial function in Caucasian and Chinese women before and after the menopause. Maturitas, 35, 31-37.
  • Raitakari, O., Celermajer, D. (2000). Flow-mediated dilatation. British Journal of Clinical Pharmacology, 50, 397-404.
  • Miller, O., Tang, S., Keech, A., Pigott, N., Beller, E., Celermajer, D. (2000). Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. The Lancet, 356(9240), 1464-1469.
  • Hornung, T., Celermajer, D., Sholler, G., Miller, O. (2000). Is nitric oxide implicated in pulmonary arteriovenous fistula formation? Pediatric Cardiology.
  • Graham, T., Bernardel, G., Mellen, B., Celermajer, D. (2000). Long term outcome in congenitally corrected transposition of the great arteries. Journal of the American College of Cardiology, 36(1), 255-261.
  • Raitakari, O., Adams, M., McCredie, R., Griffiths, K., Stocker, R., Celermajer, D. (2000). Oral vitamin C and endothelial function in smokers: acute improvement, but no sustained beneficial effect. Journal of the American College of Cardiology, 35, 1616-1621.
  • Raitakari, O., Adams, M., McCredie, R., Griffiths, K., Stocker, R., Celermajer, D. (2000). Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. Journal of the American College of Cardiology, 35, 1616-1621.
  • Simons, L., Von Konigsmark, M., Simons, J., Celermajer, D. (2000). Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy post-menopausal women. The American Journal of Cardiology, 85, 1297-1301.
  • Raitakari, O., Lai, N., Griffiths, K., McCredie, R., Sullivan, D., Celermajer, D. (2000). Preserved endothelial function and enhanced peripheral vasodilation in humans after a fatty meal. Journal of the American College of Cardiology, 36, 417-422.
  • Lau, A., Witting, P., Chaufour, X., Celermajer, D., Pettersson, K., Stocker, R. (2000). Protective effects of probucol in two animal models of atherosclerosis. Redox Report, 5, 116-118.
  • Celermajer, D. (2000). Risk factors for Australian children. Medical Journal of Australia, 173, S11-12.
  • Millane, T., Bernard, E., Jaeggi, E., Uren, R., Cartmill, T., Hawker, R., Homan-Giles, R., Celermajer, D. (2000). Role of ischemia and infarction in the late right ventricular dysfunction following atrial repair of transposition of the great arteries. Journal of the American College of Cardiology, 35, 1661-1668.
  • Raitakari, O., Celermajer, D. (2000). Testing for endothelial dysfunction. Annals of Internal Medicine, 32, 293-304.
  • Woo, K., Chook, P., Leong, H., Huang, X., Celermajer, D. (2000). The impact of heavy passive smoking on arterial endothelial function in modernized Chinese. Journal of the American College of Cardiology, 36, 1228-1232.
  • Premawardhana, U., Hoskins, M., Celermajer, D. (2000). Transvenous ultrasound in baboons; a novel window to the cardiovascular system. Clinical Science, 99, 141-147.

Conferences

  • Celermajer, D. (2006). A new era of management in pulmonary hypertension. World Congress of Cardiology.
  • Celermajer, D. (2006). Endothelial function in humans. Jagellonian Medical Research Foundation.
  • Chow, C., McQuillan, B., Raju, K., Raju, R., Celermajer, D. (2006). High levels of subclinical atherosclerosis in rural south Asian Indians could be explained by impaired protection by HDL. Annual Scientific Session of the American College of Cardiology (2006), United States: Elsevier Inc.
  • Celermajer, D. (2006). How early should we measure endothelial dysfunction? World Congress of Cardiology.
  • Celermajer, D. (2006). Physiology of the post-coarctation aorta. Image et Function Seminar.
  • Woo, K., Yip, T., Kwong, S., Chook, P., Hu, Y., HUang, X., Woo, L., Celermajer, D. (2006). The impact of vitamin B12 and folic acid supplementation on atherosclerosis in rural Chinese: A novel strategy for atherosclerosis prevention in China. World Congress of Cardiology 2006, United Kingdom: Oxford University Press.
  • Celermajer, D. (2005). Adult congenital heart disease. Echo Australia Meeting.
  • Celermajer, D. (2005). Cardiovascular implications of Childhood Obesity. World Congress of Paediatric Cardiology and Cardiac Surgery.
  • Celermajer, D. (2005). Endothelin and pulmonary hypertension. Australian Pulmonary Hypertension Experts Meeting.
  • Celermajer, D. (2005). Prevention of long-term cardiovascular disease in children. World Congress of Paediatric Cardiology and Cardiac Surgery.
  • Celermajer, D. (2005). Putting patients first. 2nd Scientific Symposium, Dual ERA.
  • Celermajer, D. (2005). Quality of Life in Pulmonary Hypertension. 4th Scientific Symposium on Endothelin-Related Diseases.
  • Celermajer, D. (2005). Selective endothelin-A antagonism is not superior to dual endothelin antagonism in the treatment of pulmonary artery hypertension. American Thoracic Society annual scientific sessions.
  • Celermajer, D. (2004). Androgens and atherosclerosis. International Society for Heart Research Scientific Sessions.
  • Celermajer, D. (2004). Androgens and the heart. Endocrine Society Of Australia.
  • Celermajer, D. (2004). Childhood obesity and atherosclerosis – keynote Lecture. South African Heart Association.
  • Celermajer, D. (2004). Cholesterol lowering and atherosclerosis. International Clinical Trials Symposium.
  • Celermajer, D. (2004). Closing holes in the heart percutaneously – state of the art. SAARC annual scientific sessions.
  • Celermajer, D. (2004). Dual cholesterol inhibition. South African Heart Association.
  • Celermajer, D. (2004). Fetal origins of atherosclerosis. South African Heart Association.
  • Celermajer, D. (2004). Following the sick aorta. Cardiac Society of Australia and New Zealand.
  • Celermajer, D. (2004). Interventions for adults congenital heart disease. South African Heart Association.
  • Celermajer, D. (2004). The endothelium for cardiologists. Cardiac Society of Australia and New Zealand.
  • Celermajer, D. (2004). Vascular biology and obesity – Keynote Lecture. 6th Hong Kong East Meets West Symposium.
  • Celermajer, D. (2003). ACE-inhibitors and long-term outcomes. Satellite to the American Heart Association.
  • Celermajer, D. (2003). Ageing and cardiovascular disease. Life Extension Symposium.
  • Celermajer, D. (2003). Heart disease in Australia. Royal Society of New South Wales, Melbourne: University of Melbourne.
  • Celermajer, D. (2003). Molecular effects of androgens on the vasculature. Cardiology Grand Rounds, Oxford: Oxford University Press.
  • Celermajer, D. (2003). Non-invasive detection of atherosclerosis. Eleventh Annual Spring Desert Cardiovascular Update.
  • Celermajer, D. (2003). Sex and the heart. 24th Panhellenic Cardiological Conference.
  • Celermajer, D. (2003). Size of plaque doesn't matter. Eleventh Annual Spring Desert Cardiovascular Update.
  • Celermajer, D. (2002). Angiotensin II and atherogenesis. Canadian Vascular Biology Working Group.
  • Celermajer, D. (2002). International Cardiovascular Professor Program – Pfizer Canada – lecture tour of Vancouver. Lecture tour of Vancouver.
  • Celermajer, D. (2002). Non-invasive detection of presymptomatic atherosclerosis. Hong Kong College of Cardiology Annual Scientific Sessions.
  • Celermajer, D. (2002). Size (of plaque) doesn't matter – the new biology of atherosclerosis. South African Cardiac Society.
  • Celermajer, D. (2002). Size of plaque and atherosclerosis risk. Hong Kong College of Cardiology Annual General Meeting.
  • Celermajer, D. (2002). Unresolved questions in hypertension. European Stroke Association Annual Scientific Sessions.
  • Celermajer, D. (2001). Angiotensin and Vascular Biology. Taiwanese Heart Association Symposium.
  • Celermajer, D. (2001). Brachial artery ultrasound and atherosclerosis. Australasian Society for Ultrasound in Medicine.
  • Celermajer, D. (2001). Impact of New Diagnostic and Intervention Options on Prognosis in Coronary Disease. International Congress of Life and Health Assurance.
  • Celermajer, D. (2000). ACE inhibition and atherogenesis. International tissue ACE symposium.
  • Celermajer, D. (2000). Benefits of Aggressive Lipid Lowering. Indonesia Atherosclerosis Society.
  • Celermajer, D. (2000). Early Detection of Atherosclerosis. South African Heart Association.
  • Celermajer, D. (2000). Inflammation in coronary disease. WHF Cardiology Year 2000 Course.
  • Celermajer, D. (2000). New techniques for detecting coronary atherosclerosis. European Society of Cardiology.
  • Celermajer, D. (2000). Nitric Oxide and Atherosclerosis. Hong Kong College of Cardiology Annual Scientific Sessions.
  • Celermajer, D. (2000). Nitric Oxide and the arterial endothelium. Taiwan Cardiac Society.
  • Celermajer, D. (2000). Obesity and Vascular Disease. South African Heart Association.
  • Celermajer, D. (2000). Recent advances in atherosclerosis. Lebanese Heart Association.
  • Celermajer, D. (2000). Sex Steroids and the Heart. South African Heart Association.
  • Celermajer, D. (2000). The effects of risk factors and race on endothelial function. International Atherosclerosis Society.
  • Celermajer, D. (2000). The Endothelium and Angiotensin. American Heart Association. High Blood Pressure Research, American Heart Association: American Heart Association.
  • Celermajer, D. (2000). The role of antioxidants in atherosclerosis. International Faculty on Endothelial Function.

Working Paper Internal

  • Kerridge, I., Stewart, G., Raper, M., Celermajer, D., Willcock, S. (2004). "The Future of Medicine" - What is wrong with medicine today? and Where is the future of medicine?.

2014

  • Dunn, L., Simpson, P., Prosser, H., Lecce (Venuto), L., Yuen, S., Buckle, A., Sieveking, D., Vanags, L., Lim, P., Chow, R., Bao, B., Davies, M., Celermajer, D., Bursill, C., Ng, M., et al (2014). A Critical Role for Thioredoxin Interacting Protein in Diabetes-Related Impairment of Angiogenesis. Diabetes, 63(2), 675-687. [More Information]
  • Ganigara, M., Collins, N., Tanous, D., Celermajer, D., Puranik, R. (2014). Anomalous left anterior descending coronary artery from the pulmonary artery - The role of cardiac MRI. International Journal of Cardiology, 172(1), e172-e174. [More Information]
  • Chow, V., Yeoh, T., Ng, A., Pasqualon, T., Scott, E., Plater, J., Whitwell, B., Hanzek, D., Chung, T., Thomas, L., Celermajer, D., Kritharides, L. (2014). Asymptomatic left ventricular dysfunction with long-term clozapine treatment for schizophrenia:a multicentre cross-sectional cohort study. Open Heart, 1, 1-10. [More Information]
  • Cordina, R., Grieve, S., Barnett, M., Lagopoulos, J., Malitz, N., Celermajer, D. (2014). Brain volumetric, regional cortical thickness and radiographic findings in adults with cyanotic congenital heart disease. NeuroImage: Clinical, 4, 319-325. [More Information]
  • Padang, R., Dennis, M., Semsarian, C., Bannon, P., Tanous, D., Celermajer, D., Puranik, R. (2014). Detection of Serious Complications by MR Imaging in Asymptomatic Young Adults with Repaired Coarctation of the Aorta. Heart, Lung and Circulation, 23(4), 332-338. [More Information]
  • Skilton, M., Siitonen, N., Wurtz, P., Viikari, J., Juonala, M., Seppala, I., Laitinen, T., Lehtimaki, T., Taittonen, L., Kahonen, M., Celermajer, D., et al (2014). High birth weight is associated with obesity and increased carotid wall thickness in young adults: the cardiovascular risk in young Finns study. Arteriosclerosis, Thrombosis, and Vascular Biology, 34(5), 1064-1068. [More Information]
  • McGrath, K., Li, X., Whitworth, P., Kasz, R., Tan, J., McLennan, S., Celermajer, D., Barter, P., Rye, K., Heather, A. (2014). High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation. Journal of Lipid Research (Online), 55(3), 421-430. [More Information]
  • Kapellas, K., Skilton, M., Maple-Brown, L., Do, L., Bartold, P., O'Dea, K., Brown, A., Celermajer, D., Jamieson, L. (2014). Periodontal disease and dental caries among Indigenous Australians living in the Northern Territory, Australia. Australian Dental Journal, 59(1), 93-99. [More Information]
  • Lau, E., Bailey, D., Bailey, E., Torzillo, P., Roach, P., Schembri, G., Corte, T., Celermajer, D. (2014). Pulmonary hypertension leads to a loss of gravity dependent redistribution of regional lung perfusion: a SPECT/CT study. Heart, 100(1), 47-53. [More Information]
  • O'Meagher, S., Ganigara, M., Munoz, P., Tanous, D., Chard, R., Celermajer, D., Puranik, R. (2014). Right Ventricular Outflow Tract Enlargement Prior to Pulmonary Valve Replacement is Associated with Poorer Structural and Functional Outcomes, in Adults with Repaired Tetralogy of Fallot. Heart, Lung and Circulation, 23(5), 482-488. [More Information]
  • Iyengar, A., Winlaw, D., Galati, J., Gentles, T., Weintraub, R., Justo, R., Wheaton, G., Bullock, A., Celermajer, D., d'Udekem, Y. (2014). The Australia and New Zealand Fontan Registry: description and initial results from the first population-based Fontan registry. Internal Medicine Journal, 44(2), 148-155. [More Information]
  • Skilton, M., Sullivan, T., Ayer, J., Garden, F., Harmer, J., Leeder, S., Toelle, B., Webb, K., Marks, G., Celermajer, D. (2014). Weight gain in infancy is associated with carotid extra-medial thickness in later childhood. Atherosclerosis, 233(2), 370-374. [More Information]

2013

  • Lau, E., Morgan, P., Belousova, E., Toelle, B., Ayer, J., Celermajer, D., Marks, G. (2013). Asymmetric dimethylarginine and asthma: results from the Childhood Asthma Prevention Study. The European Respiratory Journal, 41(5), 1234-1237. [More Information]
  • Low, A., Celermajer, D. (2013). Author reply. Internal Medicine Journal, 43(5), 609-609. [More Information]
  • O'Meagher, S., Choudhary, P., Duflou, J., Puranik, R., Celermajer, D. (2013). Causes of death in tetralogy of Fallot in adults - An autopsy study. International Journal of Cardiology, 168(2), 1547-1548. [More Information]
  • Marijon, E., Bougouin, W., Celermajer, D., Perier, M., Dumas, F., Benameur, N., Karam, N., Lamhaut, L., Tafflet, M., Mustafic, H., et al (2013). Characteristics and outcomes of sudden cardiac arrest during sports in women. Circulation. Arrhythmia and Electrophysiology, 6(6), 1185-1191. [More Information]
  • Levy, M., Bonnet, D., Mauge, L., Celermajer, D., Gaussem, P., Smadja, D. (2013). Circulating endothelial cells in refractory pulmonary hypertension in children: markers of treatment efficacy and clinical worsening. PLoS One, 8(6), 1-10. [More Information]
  • Levy, M., Celermajer, D., Szezepanski, I., Boudjemline, Y., Bonnet, D. (2013). Do tertiary paediatric hospitals deal with the same spectrum of paediatric pulmonary hypertension as multicentre registries? The European Respiratory Journal, 41(1), 236-239. [More Information]
  • Simpson, P., Hoyos, C., Celermajer, D., Liu, P., Ng, M. (2013). Effects of continuous positive airway pressure on endothelial function and circulating progenitor cells in obstructive sleep apnoea: A randomised sham-controlled study. International Journal of Cardiology, 168(3), 2042-2048. [More Information]
  • Kapellas, K., Do, L., Bartold, M., Skilton, M., Maple-Brown, L., O'Dea, K., Brown, A., Celermajer, D., Slade, G., Jamieson, L. (2013). Effects of full-mouth scaling on the periodontal health of Indigenous Australians: a randomized controlled trial. Journal of Clinical Periodontology, 40(11), 1016-1024. [More Information]
  • Beurtheret, S., Mordant, P., Paoletti, X., Marijon, E., Celermajer, D., Leger, P., Pavie, A., Combes, A., Leprince, P. (2013). Emergency circulatory support in refractory cardiogenic shock patients in remote institutions: a pilot study (the cardiac-RESCUE program). European Heart Journal, 34(2), 112-120. [More Information]
  • Celermajer, D., Neal, B. (2013). Excessive Sodium Intake and Cardiovascular Disease: A-Salting Our Vessels. Journal of the American College of Cardiology, 61(3), 344-345. [More Information]
  • Skilton, M., Mikkila, V., Wurtz, P., Ala-Korpela, M., Sim, K., Soininen, P., Kangas, A., Viikari, J., Juonala, M., Laitinen, T., Celermajer, D., et al (2013). Fetal growth, omega-3 (n-3) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The Cardiovascular Risk in Young Finns Study 1–3. The American Journal of Clinical Nutrition, 97(1), 58-65. [More Information]
  • Plichart, M., Thomas, F., Empana, J., Bean, K., Perier, M., Celermajer, D., Hanona, O., Danchin, N., Pannier, B., Jouven, X. (2013). Gender-specific trends in heart rate in the general population from 1992-2007: a study of 226,288 French adults. European Journal of Preventive Cardiology, 20(1), 61-72. [More Information]
  • Skilton, M., Raitakari, O., Celermajer, D. (2013). High Intake of Dietary Long-Chain {omega}-3 Fatty Acids Is Associated With Lower Blood Pressure in Children Born With Low Birth Weight: NHANES 2003-2008. Hypertension, 61(5), 972-976. [More Information]
  • Canniffe, C., Ou, P., Walsh, K., Bonnet, D., Celermajer, D. (2013). Hypertension after repair of aortic coarctation - A systematic review. International Journal of Cardiology, 167(6), 2456-2461. [More Information]
  • Hu, Y., Wei, A., Chook, P., Yin, Y., Cheng, W., Wu, M., Celermajer, D., Woo, K. (2013). Impact of non-cardiovascular surgery on reactive hyperaemia and arterial endothelial function. Clinical and Experimental Pharmacology and Physiology, 40(7), 466-472. [More Information]
  • Marijon, E., Bougouin, W., Perier, M., Celermajer, D., Jouven, X. (2013). Incidence of sports-related sudden death in France by specific sports and sex. JAMA, 310(6), 642-643. [More Information]
  • Marijon, E., Bougouin, W., Celermajer, D., Perier, M., Benameur, N., Lamhaut, L., Karam, N., Dumas, F., Tafflet, M., Prugger, C., et al (2013). Major regional disparities in outcomes after sudden cardiac arrest during sports. European Heart Journal, 34(47), 3632-3640. [More Information]
  • Ou, P., Khraiche, D., Celermajer, D., Agnoletti, G., Le Quan Sang, K., Thalabard, J., Quintin, M., Raisky, O., Vouhe, P., Sidi, D., et al (2013). Mechanisms of coronary complications after the arterial switch for transposition of the great arteries. The Journal of Thoracic and Cardiovascular Surgery, 145(5), 1263-1269. [More Information]
  • Marijon, E., Tafflet, M., Antero-Jacquemin, J., El Helou, N., Berthelot, G., Celermajer, D., Bougouin, W., Combes, N., Hermine, O., Empana, J., et al (2013). Mortality of French participants in the Tour de France (1947-2012). European Heart Journal, 34(40), 3145-3150. [More Information]
  • O'Meagher, S., Celermajer, D., Puranik, R. (2013). Preserved stroke volume late after tetralogy repair, despite severe right ventricular dilatation. Heart, 99(24), 1875-1876. [More Information]
  • Lau, E., Jaijee, S., Melehan, K., Wong, K., Yee, B., Grunstein, R., Celermajer, D. (2013). Prevalence of patent foramen ovale and its impact on oxygen desaturation in obstructive sleep apnea. International Journal of Cardiology, 165(1), 35-40. [More Information]
  • Cordina, R., O'Meagher, S., Karmali, A., Rae, C., Liess, C., Kemp, G., Puranik, R., Singh, N., Celermajer, D. (2013). Resistance training improves cardiac output, exercise capacity and tolerance to positive airway pressure in Fontan physiology. International Journal of Cardiology, 168(2), 780-788. [More Information]
  • Jaijee, S., O'Rourke, R., Puranik, R., Slaughter, R., Strugnal, W., Celermajer, D., Kermeen, F. (2013). Right to left ventricular volume ratio: A novel marker of disease severity in chronic thromboembolic pulmonary hypertension. IJC Heart & Vessels, 1, 17-21. [More Information]
  • Low, A., Fowler, D., Manghani, M., Young, I., Garsia, R., Torzillo, P., Youssef, P., Celermajer, D. (2013). Screening and Treating Pulmonary Arterial Hypertension in a Tertiary Hospital-based Multidisciplinary Clinic: The First 200 Patients. Internal Medicine Journal, 43(1), 32-37. [More Information]
  • Cordina, R., O'Meagher, S., Gould, H., Rae, C., Kemp, G., Pasco, J., Celermajer, D. (2013). Skeletal muscle abnormalities and exercise capacity in adults with a Fontan circulation. Heart, 99(20), 1530-1534. [More Information]
  • Ladouceur, M., Kachenoura, N., Lefort, M., Redheuil, A., Bonnet, D., Celermajer, D., Iserin, L., Mousseaux, E. (2013). Structure and function of the ascending aorta in palliated transposition of the great arteries. International Journal of Cardiology, 165(3), 458-462. [More Information]
  • Offen, S., Celermajer, D., Semsarian, C., Puranik, R. (2013). The role of diastolic filling in preserving left ventricular stroke volume - An MRI study. International Journal of Cardiology, 168(2), 1596-1598. [More Information]
  • Schuuring, M., Bouma, B., Cordina, R., Gatzoulis, M., Budts, W., Mullen, M., Vis, J., Celermajer, D., Mulder, B. (2013). Treatment of segmental pulmonary artery hypertension in adults with congenital heart disease. International Journal of Cardiology, 164(1), 106-110. [More Information]
  • Blyton, D., Skilton, M., Edwards, N., Hennessy, A., Celermajer, D., Sullivan, C. (2013). Treatment of sleep disordered breathing reverses low fetal activity levels in preeclampsia. Sleep, 36(1), 15-21. [More Information]
  • Simonneau, G., Gatzoulis, M., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Angel Gomez Sanchez, M., Kumar, R., Landzberg, M., Machado, R., et al (2013). Updated Clinical Classification of Pulmonary Hypertension. Journal of the American College of Cardiology, 62(25 Suppl D), D34-D41. [More Information]
  • Skilton, M., Marks, G., Ayer, J., Garden, F., Garnett, S., Harmer, J., Leeder, S., Toelle, B., Webb, K., Baur, L., Celermajer, D. (2013). Weight gain in infancy and vascular risk factors in later childhood. Pediatrics, 131(6), e1821-e1828. [More Information]

2012

  • Lau, E., Iyer, N., Ilsar, R., Bailey, B., Adams, M., Celermajer, D. (2012). Abnormal Pulmonary Artery Stiffness in Pulmonary Arterial Hypertension: In Vivo Study with Intravascular Ultrasound. PLoS One, 7(3), 1-6. [More Information]
  • McGrath, K., Li, X., Gaus, K., Williams, P., Celermajer, D., Handelsman, D., Heather, A. (2012). Androgens Rapidly Activate Nuclear Factor-Kappa B via Intracellular Ca2 Signalling in Human Vascular Endothelial Cells. Journal of Steroids & Hormonal Science, S2, 1-6. [More Information]
  • Ting, R., Keech, A., Drury, P., Donoghoe, M., Hedley, J., Jenkins, A., Davis, T., Lehto, S., Celermajer, D., Simes, R., Rajamani, K., et al (2012). Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment - The FIELD Study. Diabetes Care, 35(2), 218-225. [More Information]
  • Celermajer, D., Chow, C., Marijon, E., Anstey, N., Woo, K. (2012). Cardiovascular Disease in the Developing World: Prevalences, Patterns, and the Potential of Early Disease Detection. Journal of the American College of Cardiology, 60(14), 1207-1216. [More Information]
  • Skilton, M., Sullivan, T., Ayer, J., Harmer, J., Toelle, B., Webb, K., Marks, G., Celermajer, D. (2012). Carotid extra-medial thickness in childhood: Early life effects on the arterial adventitia. Atherosclerosis, 222(2), 478-482. [More Information]
  • Rose, M., Strange, G., King, I., Arnuop, S., Vidmar, S., O'Donnell, C., Kermeen, F., Grigg, L., Weintraub, R., Celermajer, D. (2012). Congenital heart disease-associated pulmonary arterial hypertension: preliminary results from a novel registry. Internal Medicine Journal, 42(8), 874-879. [More Information]
  • Dalton, B., McNeil, K., Keogh, A., Williams, T., Proudman, S., Gabbay, E., Kotlyar, E., Weintraub, R., Kermeen, F., Celermajer, D., et al (2012). Design and delivery of an e-learning curriculum for physicians involved in the management of pulmonary hypertension. International Journal of Clinical Practice, 66(11), 1117-1124. [More Information]
  • O'Meagher, S., Munoz, P., Alison, J., Young, I., Tanous, D., Celermajer, D., Puranik, R. (2012). Exercise capacity and stroke volume are preserved late after tetralogy repair, despite severe right ventricular dilatation. Heart, 98(21), 1595-1599. [More Information]
  • Talib, J., Pattison, D., Harmer, J., Celermajer, D., Davies, M. (2012). High plasma thiocyanate levels modulate protein damage induced by myeloperoxidase and perturb measurement of 3-chlorotyrosine. Free Radical Biology and Medicine, 53(1), 20-29. [More Information]
  • Skilton, M., Ayer, J., Harmer, J., Webb, K., Leeder, S., Marks, G., Celermajer, D. (2012). Impaired Fetal Growth and Arterial Wall Thickening: A Randomized Trial of Omega-3 Supplementation. Pediatrics, 129(3), e698-e703. [More Information]
  • Don, G., Joseph, F., Celermajer, D., Corte, T. (2012). Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan. Internal Medicine Journal, 42(12), 1351-1354. [More Information]
  • Zahnd, G., Vray, D., Serusclat, A., Alibay, D., Bartold, M., Brown, A., Durand, M., Jamieson, L., Kapellas, K., Maple-Brown, L., Celermajer, D., Skilton, M., et al (2012). Longitudinal displacement of the carotid wall and cardiovascular risk factors: associations with aging, adiposity, blood pressure and periodontal disease independent of cross-sectional distensibility and intima-media thickness. Ultrasound in Medicine and Biology, 38(10), 1705-1715. [More Information]
  • Morton, J., Zoungas, S., Li, Q., Patel, A., Chalmers, J., Woodward, M., Celermajer, D., Beulens, J., Stolk, R., Glasziou, P., Ng, M. (2012). Low HDL Cholesterol and the Risk of Diabetic Nephropathy and Retinopathy: Results of the ADVANCE study. Diabetes Care, 35(11), 2201-2206. [More Information]
  • Celermajer, D. (2012). Manipulating nature: Might there be a cardiovascular price to pay for the miracle of assisted conception? Circulation, 125(15), 1832-1834. [More Information]
  • Thakkar, V., Stevens, W., Prior, D., Moore, O., Byron, J., Liew, D., Patterson, K., Hissaria, P., Roddy, J., Zochling, J., Celermajer, D., Youssef, P., et al (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research and Therapy, 14(3), 1-10. [More Information]
  • Marshall, N., Ayer, J., Toelle, B., Phillips, C., Grunstein, R., Celermajer, D., Marks, G. (2012). Parentally Reported Snoring Is Not Enough Information To Justify Treatment. Journal of Paediatrics and Child Health, 48(1), 78-78. [More Information]
  • Marijon, E., Mirabel, M., Celermajer, D., Jouven, X. (2012). Rheumatic heart disease. The Lancet, 379(9819), 953-964. [More Information]
  • Mirabel, M., Celermajer, D., Ferreira, B., Tafflet, M., Perier, M., Karam, N., Mocumbi, A., Jani, D., Sidi, D., Jouven, X., Marijon, E. (2012). Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach. European journal of Echocardiography, 13(12), 1024-1029. [More Information]
  • Golzan, S., Leaney, J., Cordina, R., Avolio, A., Celermajer, D., Graham, S. (2012). Spontaneous retinal venous pulsatility in patients with cyanotic congenital heart disease. Heart and Vessels: an international journal, 27(6), 618-623. [More Information]
  • Cordina, R., Celermajer, D., McGuire, M. (2012). Systemic venous anatomy in congenital heart disease: implications for electrophysiologic testing and catheter ablation. Journal of Interventional Cardiac Electrophysiology, 33(2), 143-149. [More Information]
  • Flammer, A., Anderson, T., Celermajer, D., Creager, M., Deanfield, J., Ganz, P., Hamburg, N., Luscher, T., Shechter, M., Taddei, S., et al (2012). The assessment of endothelial function: from research into clinical practice. Circulation, 126(6), 753-767. [More Information]
  • Rangan, A., Flood, V., Denyer, G., Ayer, J., Webb, K., Marks, G., Celermajer, D., Gill, T. (2012). The effect of dairy consumption on blood pressure in mid-childhood: CAPS cohort study. European Journal of Clinical Nutrition, 66(6), 652-657. [More Information]
  • Kwok, T., Chook, P., Qiao, M., Tam, L., Poon, Y., Ahuja, A., Woo, J., Celermajer, D., Woo, K. (2012). Vitamin B-12 supplementation improves arterial function in vegetarians with subnormal vitamin B-12 status. The Journal of Nutrition, Health and Aging, 16(6), 569-573. [More Information]

2011

  • Levy, M., Celermajer, D., Bourges-Petit, E., Del Cerro, M., Bajolle, F., Bonnet, D. (2011). Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension. The Journal of Pediatrics, 158(4), 584-588. [More Information]
  • Davis, J., Darcy, C., Yeo, T., Jones, C., McNeil, Y., Stephens, D., Celermajer, D., Anstey, N. (2011). Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PLoS One, 6(2), e17260-1-e17260-6. [More Information]
  • Plichart, M., Celermajer, D., Zureik, M., Helmer, C., Jouven, X., Ritchie, K., Tzourio, C., Ducimetière, P., Empana, J. (2011). Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis, 219(2), 917-924. [More Information]
  • Lau, E., Manes, A., Celermajer, D., Galie, N. (2011). Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward. European Heart Journal, 32(20), 2489-2498. [More Information]
  • Skilton, M., Viikari, J., Juonala, M., Laitinen, T., Lehtimaki, T., Taittonen, L., Kahonen, M., Celermajer, D., Raitakari, O. (2011). Fetal Growth and Preterm Birth Influence Cardiovascular Risk Factors and Arterial Health in Young Adults: The Cardiovascular Risk in Young Finns Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 31(12), 2975-2981. [More Information]
  • Jouven, X., Escolano, S., Celermajer, D., Empana, J., Bingham, A., Hermine, O., Desnos, M., Perier, M., Marijon, E., Ducimetiere, P. (2011). Heart rate and risk of cancer death in healthy men. PLoS One, 6(8), e21310 - 1-e21310 - 7. [More Information]
  • Morgan, P., Pattison, D., Talib, J., Summers, F., Harmer, J., Celermajer, D., Hawkins, C., Davies, M. (2011). High plasma thiocyanate levels in smokers are a key determinant of thiol oxidation induced by myeloperoxidase. Free Radical Biology and Medicine, 51(9), 1815-1822. [More Information]
  • Ng, A., Chung, T., Yong, A., Wong, H., Chow, V., Celermajer, D., Kritharides, L. (2011). Long-Term Cardiovascular and Noncardiovascular Mortality of 1023 Patients With Confirmed Acute Pulmonary Embolism. Circulation. Cardiovascular Quality and Outcomes, 4(1), 122-128. [More Information]
  • Ayer, J., Belousova, E., Harmer, J., Toelle, B., Celermajer, D., Marks, G. (2011). Lung Function Is Associated with Arterial Stiffness in Children. PLoS One, 6(10), e26303 - 1-e26303 - 4. [More Information]
  • Ayer, J., Belousova, E., Harmer, J., David, C., Marks, G., Celermajer, D. (2011). Maternal cigarette smoking is associated with reduced high-density lipoprotein cholesterol in healthy 8-year-old children. European Heart Journal, 32(19), 2446-2453. [More Information]
  • Roberts, P., Boudjemline, Y., Cheatham, J., Eicken, A., Ewert, P., McElhinney, D., Hill, S., Berger, F., Khan, D., Schranz, D., Celermajer, D., et al (2011). Percutaneous Tricuspid Valve Replacement in Congenital and Acquired Heart Disease. Journal of the American College of Cardiology, 58(2), 117-122. [More Information]
  • Ayer, J., Harmer, J., David, C., Steinbeck, K., Seale, J., Celermajer, D. (2011). Severe obesity is associated with impaired arterial smooth muscle function in young adults. Obesity, 19(1), 54-60.
  • Marshall, N., Ayer, J., Toelle, B., Harmer, J., Phillips, C., Grunstein, R., Celermajer, D., Marks, G. (2011). Snoring is not associated with adverse effects on blood pressure, arterial structure or function in 8-year-old children: The Childhood Asthma Prevention Study (CAPS). Journal of Paediatrics and Child Health, 47(8), 518-523. [More Information]
  • Marijon, E., Tafflet, M., Celermajer, D., Dumas, F., Perier, M., Mustafic, H., Toussaint, J., Desnos, M., Rieu, M., Benameur, N., et al (2011). Sports-related sudden death in the general population. Circulation, 124(6), 672-681. [More Information]
  • Skilton, M., Maple-Brown, L., Kapellas, K., Celermajer, D., Bartold, P., Brown, A., O'Dea, K., Slade, G., Jamieson, L. (2011). The effect of a periodontal intervention on cardiovascular risk markers in Indigenous Australians with periodontal disease: the PerioCardio study. BMC Public Health, 11(1), 729-1-729-8. [More Information]
  • Iyer, N., Lau, E., Ilsar, R., Celermajer, D. (2011). Treatment responsiveness in pulmonary arterial hypertension-Preliminary report on serial intra-arterial Doppler flow velocity waveform measurements. International Journal of Cardiology, 153(2), 219-221. [More Information]
  • Smadja, D., Mauge, L., Gaussem, P., d'Audigier, C., Israel-Biet, D., Celermajer, D., Bonnet, D., Levy, M. (2011). Treprostinil increases the number and angiogenic potential of endothelial progenitor cells in children with pulmonary hypertension. Angiogenesis, 14(1), 17-27. [More Information]
  • Changsirivathanathamrong, D., Wang, Y., Rajbhandari, D., Maghzal, G., Mak, W., Woolfe, C., Duflou, J., Gebski, V., Dos Remedios, C., Celermajer, D., Stocker, R. (2011). Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis. Critical Care Medicine, 39(12), 2678-2683. [More Information]

2010

  • Sieveking, D., Lim, P., Chow, R., Dunn, L., Bao, B., McGrath, K., Heather, A., Handelsman, D., Celermajer, D., Ng, M. (2010). A sex-specific role for androgens in angiogenesis. The Journal of Experimental Medicine, 207(2), 345-352. [More Information]
  • Davis, J., Yeo, T., Piera, K., Woodberry, T., Celermajer, D., Stephens, D., Anstey, N. (2010). Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivity. Critical Care, 14: R89(3), 1-8. [More Information]
  • Patel, S., Di Bartolo, B., Nakhla, S., Heather, A., Mitchell, T., Jessup, W., Celermajer, D., Barter, P., Rye, K. (2010). Anti-inflammatory effects of apolipoprotein A-I in the rabbit. Atherosclerosis, 212(2), 392-397. [More Information]
  • Ilsar, R., Levitt, J., Ng, M., Kritharides, L., Celermajer, D. (2010). Bosentan and improved pulmonary endothelial function in pulmonary arterial hypertension. The European Respiratory Journal, 36(6), 1483-1485. [More Information]
  • Ayer, J., Harmer, J., Marks, G., Avolio, A., Celermajer, D. (2010). Central arterial pulse wave augmentation is greater in girls than boys, independent of height. Journal of Hypertension, 28(2), 306-313.
  • Cordina, R., Celermajer, D. (2010). Chronic cyanosis and vascular function: implications for patients with cyanotic congenital heart disease. Cardiology in the Young, 20(3), 242-53. [More Information]
  • Puranik, R., Celermajer, D., Muthurangu, V., Taylor, A., Puranik, R. (2010). Congenital heart disease and multi-modality imaging. Heart, Lung and Circulation, 19(3), 133-144. [More Information]
  • Ilsar, R., Chawantanpipat, C., Chan, K., Dobbins, T., Waugh, R., Hennessy, A., Celermajer, D., Ng, M. (2010). Doppler-derived Pulmonary Flow Reserve Detects Pulmonary Microvascular Obstruction in High Primates. Heart, Lung and Circulation, 19(10), 592-594. [More Information]
  • Mackie, F., Rosenberg, A., Harmer, J., Kainer, G., Celermajer, D. (2010). HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD) - a pilot study. Acta Paediatrica: Nurturing the Child, 99(10.1111/j.1651-2227.2009.01643.x), 457-459. [More Information]
  • Yeo, T., Lampah, D., Tjitra, E., Gitawati, R., Darcy, C., Jones, C., Kenangalem, E., McNeil, Y., Granger, D., Lopansri, B., Celermajer, D., et al (2010). Increased Asymmetric Dimethylarginine in Severe Falciparum Malaria: Association with Impaired Nitric Oxide Bioavailability and Fatal Outcome. P L o S Pathogens, 6(4), e1000868-1-e1000868-8. [More Information]
  • Ayer, J., Song, C., Steinbeck, K., Celermajer, D., Freedman, B. (2010). Increased Tissue Factor Activity in Monocytes from Obese Young Adults. Clinical and Experimental Pharmacology and Physiology, 37(11), 1049-1054. [More Information]
  • Wang, Y., Liu, H., McKenzie, G., Witting, P., Stasch, J., Hahn, M., Changsirivathanathamrong, D., Wu, B., Ball, H., Thomas, S., Celermajer, D., Hunt, N., Stocker, R., et al (2010). Kynurenine is an endothelium-derived relaxing factor produced during inflammation. Nature Medicine, 16(3), 279-285. [More Information]
  • Cordina, R., Celermajer, D. (2010). Late-Onset Pulmonary Arterial Hypertension After a Successful Atrial or Arterial Switch Procedure for Transposition of the Great Arteries. Pediatric Cardiology, 31(10.1007/s00246-009-9597-9), 238-241. [More Information]
  • Ayer, J., Sholler, G., Celermajer, D. (2010). Left atrial size increases with body mass index in children. International Journal of Cardiology, 141(1), 61-67. [More Information]
  • Ilsar, R., Chawantanpipat, C., Chan, K., Dobbins, T., Waugh, R., Hennessy, A., Celermajer, D., Ng, M. (2010). Measurement of pulmonary flow reserve and pulmonary index of microcirculatory resistance for detection of pulmonary microvascular obstruction. PLoS One, 5(3), e9601 - 1-e9601 - 9. [More Information]
  • Lau, E., Yee, B., Grunstein, R., Celermajer, D. (2010). Patent foramen ovale and obstructive sleep apnea: A new association? Sleep Medicine Reviews, 14(6), 391-395. [More Information]
  • Roberts, P., Spina, R., Vallely, M., Wilson, M., Bailey, B., Celermajer, D. (2010). Percutaneous tricuspid valve replacement for a stenosed bioprosthesis. Circulation. Cardiovascular Interventions, 3(4), e14-e15. [More Information]
  • Ban, C., Twigg, S., Franjic, B., Brooks, B., Celermajer, D., Yue, D., McLennan, S. (2010). Serum MMP-7 is increased in diabetic renal disease and diabetic diastolic dysfunction. Diabetes Research and Clinical Practice, 87(3), 335-341. [More Information]
  • Ayer, J., Harmer, J., David, C., Steinbeck, K., Seale, J., Celermajer, D. (2010). Severe Obesity Is Associated With Impaired Arterial Smooth Muscle Function in Young Adults. Obesity, 19(1), 54-60. [More Information]
  • Ilsar, R., Bailey, B., Dobbins, T., Celermajer, D. (2010). The Relationship Between Pulmonary Artery and Pulmonary Capillary Wedge Pressure for the Diagnosis of Pulmonary Vascular Disease. Heart, Lung and Circulation, 19(1), 38-42. [More Information]
  • Patel, S., Chung, S., White, G., Bao, B., Celermajer, D. (2010). The “atheroprotective�? mediators apolipoproteinA-I and Foxp3 are over-abundant in unstable carotid plaques. International Journal of Cardiology, 145(2), 183-187. [More Information]
  • Cordina, R., Celermajer, D. (2010). Therapeutic approaches in adults with congenital heart disease-associated pulmonary arterial hypertension. European respiratory review : an official journal of the European Respiratory Society, 19(118), 300-307. [More Information]

2009

  • Patel, S., Puranik, R., Nakhla, S., Lundmand, P., Stocker, R., Wang, X., Lambert, G., Rye, K., Barter, P., Nicholls, S., Celermajer, D. (2009). Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis, 204(2), 424-428. [More Information]
  • Ayer, J., Harmer, J., Xuan, W., Toelle, B., Webb, K., Almqvist, C., Marks, G., Celermajer, D. (2009). Dietary supplementation with n-3 polyunsaturated fatty acids in early childhood: Effects on blood pressure and arterial structure and function at age 8 y1–3. American Journal of Clinical Nutrition, 90, 438-446. [More Information]
  • Ayer, J., Harmer, J., Nakhla, S., Xuan, W., Ng, M., Raitakari, O., Marks, G., Celermajer, D. (2009). HDL-cholesterol, blood pressure, and asymmetric dimethylarginine are significantly associated with arterial wall thickness in children. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(6), 943-949. [More Information]
  • Ilsar, R., Chawantanpipat, C., Chan, K., Waugh, R., Hennessy, A., Celermajer, D., Ng, M. (2009). Measurement of pulmonary flow reserve in higher primates. Clinical and Experimental Pharmacology and Physiology, 36(8), 797-802. [More Information]
  • Ayer, J., Harmer, J., Steinbeck, K., Celermajer, D. (2009). Postprandial Vascular Reactivity in Obese and Normal Weight Young Adults. Obesity, Online(10.1038/oby.2009.331), 1-7. [More Information]
  • Chow, C., Joshi, R., Celermajer, D., Patel, A., Neal, B. (2009). Recalibration of a Framingham risk equation for a rural population in India. Journal of Epidemiology and Community Health, 63(5), 379-385. [More Information]
  • Patel, S., Drew, B., Nakhla, S., Duffy, S., Murphy, A., Barter, P., Rye, K., Chin-Dusting, J., Hoang, A., Sviridov, D., Celermajer, D., et al (2009). Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes. Journal of the American College of Cardiology, 53(11), 962-971. [More Information]
  • Celermajer, D. (2009). Wait for weight or waste" the waist the benefits of early intervention in childhood obesity.". Journal of the American College of Cardiology, 54(25), 2407-2408. [More Information]

2008

  • Agnoletti, G., Ou, P., Celermajer, D., Boudjemline, Y., Marini, D., Bonnet, D., Aggoun, Y. (2008). Acute angulation of the aortic arch predisposes a patient to ascending aortic dilatation and aortic regurgitation late after the arterial switch operation for transposition of the great arteries. The Journal of Thoracic and Cardiovascular Surgery, 135(3), 568-572. [More Information]
  • Yeo, T., Lampahc, D., Gitawatie, R., Tjitra, E., Kenangalem, E., Piera, K., Price, R., Duffull, S., Celermajer, D., Anstey, N. (2008). Angiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria. Proceedings of the National Academy of Sciences (PNAS) of the United States of America, 105(44), 17097-17102. [More Information]
  • Ou, P., Celermajer, D., Raisky, O., Jolivet, O., Buyens, F., Herment, A., Sidi, D., Bonnet, D., Mousseaux, E. (2008). Angular (Gothic) aortic arch leads to enhanced systolic wave reflection, central aortic stiffness, and increased left ventricular mass late after aortic coarctation repair: evaluation with magnetic resonance flow mapping. The Journal of Thoracic and Cardiovascular Surgery, 135(1), 62-68. [More Information]
  • Patel, S., Celermajer, D., Bao, B. (2008). Atherosclerosis - Underlying inflammatory mechanisms and clinical implications. The International Journal of Biochemistry and Cell Biology, 40(4), 576-580. [More Information]
  • Ayer, J., Almafragy, H., Patel, A., Hellyer, R., Celermajer, D. (2008). Body mass index is an independent determinant of left atrial size. Heart, Lung and Circulation, 17(1), 19-24. [More Information]
  • McGrady, M., Thanyasiri, P., Bailey, B., Celermajer, D., Adams, M. (2008). Determinants of coronary arterial flow-mediated dilatation following percutaneous coronary intervention. Catheterization and Cardiovascular Interventions, 71(3), 327-332. [More Information]
  • Chow, C., McQuillan, B., Raju, P., Iyengar, S., Raju, R., Harmer, J., Neal, B., Celermajer, D. (2008). Greater adverse effects of cholesterol and diabetes on carotid intima-media thickness in South Asian Indians: Comparison of risk factor-IMT associations in two population-based surveys. Atherosclerosis, 199(1), 116-122. [More Information]
  • Ou, P., Celermajer, D., Jolivet, O., Buyens, F., Herment, A., Sidi, D., Bonnet, D., Mousseaux, E. (2008). Increased central aortic stiffness and left ventricular mass in normotensive young subjects after successful coarctation repair. American Heart Journal, 155(1), 187-193. [More Information]
  • Puranik, R., Bao, B., Nobecourt, E., Nicholls, S., Dusting, G., Barter, P., Celermajer, D., Rye, K. (2008). Low dose apolipoprotein A-I rescues carotid arteries from inflammation in vivo. Atherosclerosis, 196(1), 240-247. [More Information]
  • Yeo, T., Lampah, D., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y., Darcy, C., Granger, D., Weinberg, J., et al, Celermajer, D. (2008). Recovery of Endothelial Function in Severe Falciparum Malaria: Relationship with Improvement in Plasma l-Arginine and Blood Lactate Concentrations. The Journal of Infectious Diseases, 198(4), 602-608. [More Information]
  • Kilian, J., Thanyasiri, P., Celermajer, D., Adams, M. (2008). Saphenous Vein Grafts Display Poor Endothelium-Dependent and Endothelium-Independent Dilation - Implications for the Pathogenesis of Vein Graft Atherosclerosis. Heart, Lung and Circulation, 17(2), 96-99. [More Information]
  • Chow, C., Naidu, S., Raju, P., Raju, R., Joshi, R., Sullivan, D., Celermajer, D., Neal, B. (2008). Significant lipid, adiposity and metabolic abnormalities amongst 4535 Indians from a developing region of rural Andhra Pradesh. Atherosclerosis, 196, 943-952. [More Information]
  • Thomas, G., Chook, P., Yip, T., Kwong, S., Chan, T., Qiao, M., Huang, X., Guo, D., Feng, J., Chan, S., Celermajer, D., et al (2008). Smoking without exception adversely affects vascular structure and function in apparently healthy Chinese: implications in global atherosclerosis prevention. International Journal of Cardiology, 128(2), 172-177. [More Information]
  • Sieveking, D., Buckle, A., Celermajer, D., Ng, M. (2008). Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. Journal of the American College of Cardiology, 51(6), 660-668. [More Information]
  • Lattimore, J., Wilcox, I., Adams, M., Kilian, J., Celermajer, D. (2008). Treatment of obstructive sleep apnoea leads to enhanced pulmonary vascular nitric oxide release. International Journal of Cardiology, 126, 229-233. [More Information]
  • Celermajer, D., Ng, M. (2008). Where there's smoke.. Journal of the American College of Cardiology, 51(18), 1772-4. [More Information]

2007

  • Puranik, R., Greaves, K., Hawker, R., Pressley, L., Robinson, P., Celermajer, D. (2007). Abnormal Right Ventricular Tissue Velocities After Repair of Congenital Heart Disease-Implications for Late Outcomes. Heart, Lung and Circulation, 16(4), 295-299. [More Information]
  • Patel, S., Drew, B., Duffy, S., Nahkla, S., Rye, K., Barter, P., Celermajer, D., Kingwell, B. (2007). Abstract 1047: Infusion of Reconstituted High Density Lipoproteins Into Humans Enhances the In Vitro Anti-Inflammatory Capacity of the High Density Lipoprotein Fraction. Circulation, 116, II_209.
  • Chandrasegaram, M., Celermajer, D., Wilson, M. (2007). Apical ballooning syndrome complicated by acute severe mitral regurgitation with left ventricular outflow obstruction – Case report. Journal of Cardiothoracic Surgery, 2(14), 1-14. [More Information]
  • Chow, C., Cardona-Morrell, M., Raju, P., Iyengar, S., Sukumar, A., Raju, C., Colman, S., Madhav, P., Raju, R., Reddy, K., Celermajer, D., Neal, B. (2007). Cardiovascular disease and risk factors among 345 adults in rural India-the Andhra Pradesh Rural Health Initiative. International Journal of Cardiology, 116(2), 180-185. [More Information]
  • Patel, S., Harmer, J., Loughnan, G., Skilton, M., Steinbeck, K., Celermajer, D. (2007). Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome. Clinical Endocrinology, 66(6), 771-777. [More Information]
  • Marijon, E., Trinquart, L., Jani, D., Jourdier, H., Garbarz, E., Mocumbi, A., Celermajer, D., Ferreira, B. (2007). Coronary heart disease and associated risk factors in sub-Saharan Africans. Journal of Human Hypertension, 21(5), 411-414.
  • Ou, P., Celermajer, D., Agnoletti, G., Brunelle, F., Vouhe, P., Sidi, D., Bonnet, D. (2007). Definitive diagnosis of pulmonary artery sling in a critically ill infant with high resolution computed tomography. Circulation, 115, e398-e399.
  • Brooks, B., Franjic, B., Ban, C., Swaraj, K., Yue, D., Celermajer, D., Twigg, S. (2007). Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes, Obesity and Metabolism, online publication(doi: 10.1111/j.1463-1326.2007.00803.x), 1-8. [More Information]
  • Celermajer, D., Marwick, T. (2007). Echocardiographic and right heart catheterization techniques in patients with pulmonary arterial hypertension. International Journal of Cardiology, 125, 294-303. [More Information]
  • Levy, M., Maurey, C., Celermajer, D., Vouhe, P., Danel, C., Bonnet, D., Israel-Biet, D. (2007). Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. Journal of the American College of Cardiology, 49(7), 803-810. [More Information]
  • Yeo, T., Lampah, D., Gitawati, R., Tjitra, E., Kenangalem, E., McNeil, Y., Darcy, C., Granger, D., Weinberg, J., Lopansri, B., Celermajer, D., et al (2007). Impaired nitric oxide bioavailability and L-arginine-reversible endothelial dysfunction in adults with falciparum malaria. The Journal of Experimental Medicine, 204(11), 2693-2704.
  • Maple-Brown, L., Piers, L., O'Rourke, M., Celermajer, D., O'Dea, K. (2007). Increased arterial stiffness in remote Indigenous Australians with high risk of cardiovascular disease. Journal of Hypertension, 25(3), 585-591. [More Information]
  • Maple-Brown, L., Cunningham, J., Celermajer, D., O'Dea, K. (2007). Increased carotid intima-media thickness in remote and urban Indigenous Australians: impact of diabetes and components of the metabolic syndrome. Clinical Endocrinology, 66(3), 419-425. [More Information]
  • Marijon, E., Ou, P., Celermajer, D., Ferreira, B., Mocumbi, A., Jani, D., Paquet, C., Jacob, S., Sidi, D., Jouven, X. (2007). Prevalence of Rheumatic Heart Disease Detected by Echocardiographic Screening. New England Journal of Medicine, 357(5), 470-476.
  • Celermajer, D. (2007). Protecting children from passive smoking. Circulation (Baltimore), 115, 3143-3144. [More Information]
  • Proudman, S., Stevens, W., Sahhar, J., Celermajer, D. (2007). Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment. Internal Medicine Journal, 37(7), 485-494.
  • Webb, R., Wilson, N., Lennon, D., Marijon, E., Celermajer, D., Jouven, X. (2007). Rheumatic Heart Disease Detected by Echocardiographic Screening. The New England Journal of Medicine, 357(20), 2088-2089. [More Information]
  • Skilton, M., Sieveking, D., Harmer, J., Franklin, J., Loughnan, G., Nakhla, S., Sullivan, D., Caterson, I., Celermajer, D. (2007). The effects of obesity and non-pharmacological weight loss on vascular and ventricular function and structure. Diabetes, Obesity and Metabolism, 10(10), 874-884. [More Information]
  • Brand-Miller, J., Dickinson, S., Barclay, A., Celermajer, D. (2007). The glycemic index and cardiovascular disease risk. Current atherosclerosis reports, 9(6), 479-85. [More Information]
  • Ou, P., Celermajer, D., Mousseux, E., Giron, A., Aggoun, Y., Szezepanski, I., Sidi, D., Bonnet, D. (2007). Vascular remodelling after "successful" repair of coarctation: impact of aortic arch geometry. Journal of the American College of Cardiology, 49(8), 883-890. [More Information]

2006

  • Celermajer, D. (2006). A new era of management in pulmonary hypertension. World Congress of Cardiology.
  • Puranik, R., Bao, B., Celermajer, D., Rye, K., Barter, P., Nicholls, S., Nobecourt, E. (2006). A single infusion of lipid free apo A1 can rescue vascular inflammation. Atherosclerosis Supplements, 7, 153.
  • Puranik, R., Nobecourt, E., Bao, B., Davies, M., Barter, P., Celermajer, D., Rye, K. (2006). Abstract 1355: The Impact of Glycation on the Anti-inflammatory Properties of High Density Lipoproteins in vivo. Circulation, 114, II-257-II-258.
  • Ou, P., Mousseaux, E., Celermajer, D., Pedroni, E., Vouhe, P., Sidi, D., Bonnet, D. (2006). Aortic arch shape deformation after coarctation surgery: effect on blood pressure response. The Journal of Thoracic and Cardiovascular Surgery, 132(5), 1105-1111. [More Information]
  • Patel, S., Celermajer, D. (2006). Assessment of vascular disease using arterial flow mediated dilatation. Pharmacological Reports, 58, 3-7. [More Information]
  • Kotlyar, E., Sy, R., Keogh, A., Kermeen, F., Macdonald, P., Hayward, C., McNeil, K., Celermajer, D. (2006). Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease. Cardiology in the Young, 16(3), 268-274. [More Information]
  • Celermajer, D., Ayer, J. (2006). Childhood risk factors for adult cardiovascular disease and primary prevention in childhood. Heart, 92(11), 1701-1706. [More Information]
  • Nicholls, S., Lundman, P., Harmer, J., Cutri, B., Griffiths, K., Rye, K., Barter, P., Celermajer, D. (2006). Consumption of saturated fat impairs the anti-inflammatory properties of high-density lipoproteins and endothelial function. Journal of the American College of Cardiology, 48(4), 715-720. [More Information]
  • Skilton, M., Celermajer, D. (2006). Endothelial dysfunction and arterial abnormalities in childhood obesity. International Journal of Obesity, 30(7), 1041-1049. [More Information]
  • Thanyasiri, P., Kathir, K., Celermajer, D., Adams, M. (2006). Endothelial dysfunction and restenosis following percutaneous coronary intervention. International Journal of Cardiology, , 1-6. [More Information]
  • Celermajer, D. (2006). Endothelial function in humans. Jagellonian Medical Research Foundation.
  • Chow, C., McQuillan, B., Raju, K., Raju, R., Celermajer, D. (2006). High levels of subclinical atherosclerosis in rural south Asian Indians could be explained by impaired protection by HDL. Annual Scientific Session of the American College of Cardiology (2006), United States: Elsevier Inc.
  • Celermajer, D. (2006). How early should we measure endothelial dysfunction? World Congress of Cardiology.
  • Lau, A., Chaufour, X., McLachlan, C., Leichtweis, S., Celermajer, D., Sullivan, C., Stocker, R. (2006). Intimal thickening after arterial balloon injury is increased by intermittent repetitive hypoxia, but intermittent repetitive hyperoxia is not protective. Atherosclerosis, 185(2), 254-263. [More Information]
  • Skilton, M., Gosby, A., Wu, B., Ho, L., Stocker, R., Caterson, I., Celermajer, D. (2006). Maternal undernutrition reduces aortic wall thickness and elastin content in offspring rats without altering endothelial function. Clinical Science, 111(4), 281-287. [More Information]
  • Celermajer, D. (2006). Physiology of the post-coarctation aorta. Image et Function Seminar.
  • Thanyasiri, P., Celermajer, D., Adams, M. (2006). Predictors of long-term outcome following percutaneous coronary intervention in patients with type 2 diabetes mellitus. Coronary Artery Disease, 17(2), 131-138. [More Information]
  • Tanous, D., Brasen, J., Choy, K., Wu, B., Kathir, K., Lau, A., Celermajer, D., Stocker, R. (2006). Probucol inhibits in-stent thrombosis and neointimal hyperplasia by promoting re-endothelialization. Atherosclerosis, 189(2), 342-349. [More Information]
  • Skilton, M., Celermajer, D. (2006). The effects of obesity-related peptides on the vasculature. Current Vascular Pharmacology, 4(1), 79-85. [More Information]
  • Woo, K., Yip, T., Kwong, S., Chook, P., Hu, Y., HUang, X., Woo, L., Celermajer, D. (2006). The impact of vitamin B12 and folic acid supplementation on atherosclerosis in rural Chinese: A novel strategy for atherosclerosis prevention in China. World Congress of Cardiology 2006, United Kingdom: Oxford University Press.
  • Chow, C., Raju, P., Raju, K., Reddy, K., Cardona-Morrell, M., Celermajer, D., Neal, B. (2006). The prevalence and management of diabetes in rural Indian Adults. (Letter). Diabetes Care, 29(7), 1717-1718. [More Information]
  • Ou, P., Celermajer, D., Calcagni, G., Brunelle, F., Bonnet, D., Sidi, D. (2006). Three-Dimensional CT Scanning: A Novel Diagnostic Modality in Congenital Heart Disease. Heart, 93(8), 908-913. [More Information]
  • Lattimore, J., Wilcox, I., Skilton, M., Langenfeld, M., Celermajer, D. (2006). Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax, 61(6), 491-495. [More Information]

2005

  • Kilian, J., Nakhla, S., Sieveking, D., Celermajer, D. (2005). Adenosine prevents neutrophil adhesion to human endothelial cells after hypoxia/reoxygenation. International Journal of Cardiology, 105(3), 322-326. [More Information]
  • Celermajer, D. (2005). Adult congenital heart disease. Echo Australia Meeting.
  • Sader, M., McGrath, K., Hill, M., Bradstock, K., Jimenez, M., Handelsman, D., Celermajer, D., Heather, A. (2005). Androgen receptor gene expression in leucocytes is hormonally regulated: implications for gender differences in disease pathogenesis. Clinical Endocrinology, 62(1), 56-63. [More Information]
  • Skilton, M., Evans, N., Griffiths, K., Harmer, J., Celermajer, D. (2005). Aortic wall thickness in newborns with intrauterine growth restriction. The Lancet, 365(9469), 1484-1486. [More Information]
  • Joshua, A., Celermajer, D., Stockler, M. (2005). Beauty is in the eye of the examiner: reaching agreement about physical signs and their value. Internal Medicine Journal, 35(3), 178-187. [More Information]
  • Celermajer, D. (2005). Brachial artery FMD with 5-minute distal cuff occlusion--a useful pathophysiological test after all!. Journal of Applied Physiology, 99(4), 1619. [More Information]
  • Celermajer, D. (2005). Cardiovascular implications of Childhood Obesity. World Congress of Paediatric Cardiology and Cardiac Surgery.
  • Maple-Brown, L., O'Rourke, M., Piers, L., Celermajer, D., O'Dea, K. (2005). Central obesity is associated with reduced peripheral wave reflection in Indigenous Australians irrespective of diabetes status. Journal of Hypertension, 23(7), 1403-1407. [More Information]
  • Chow, C., Amos, D., Celermajer, D. (2005). Cerebrovascular events in young adults after surgical repair of tetralogy of Fallot. Cardiology in the Young, 15(2), 130-132. [More Information]
  • Sieveking, D., Woo, K., Fung, K., Lundman, P., Nakhla, S., Celermajer, D. (2005). Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. International Journal of Cardiology, 105(1), 40-45. [More Information]
  • Nicholls, S., Celermajer, D., Rye, K., Barter, P., Griffiths, K., Cutri, B., Harmer, J., Lundman, P. (2005). Consumption of saturated fat impairs endothelial function and the antiinflammatory properties of high-density lipoproteins. Circulation, 112(17), U43.
  • Thanyasiri, P., Celermajer, D., Adams, M. (2005). Endothelial dysfunction occurs in peripheral circulation in patients with acute and stable coronary artery disease. American Journal of Physiology: Heart and Circulatory Physiology, 289(2), H513-H517. [More Information]
  • Celermajer, D. (2005). Endothelin and pulmonary hypertension. Australian Pulmonary Hypertension Experts Meeting.
  • Skilton, M., Lai, N., Griffiths, K., Molyneaux, L., Yue, D., Sullivan, D., Celermajer, D. (2005). Meal-related increases in vascular reactivity are impaired in older and diabetic adults: insights into roles of aging and insulin in vascular flow. American Journal of Physiology: Heart and Circulatory Physiology, 288(3), H1404-H1410. [More Information]
  • Lundman, P., Keech, A., Griffiths, K., Pillai, A., Celermajer, D. (2005). New carotid plaque formation is very common in adult patients with Type 2 diabetes mellitus. Diabetic Medicine, 22(3), 355-356. [More Information]
  • Skilton, M., Nakhla, S., Sieveking, D., Caterson, I., Celermajer, D. (2005). Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clinical and Experimental Pharmacology and Physiology, 32(10), 839-844. [More Information]
  • Celermajer, D. (2005). Prevention of long-term cardiovascular disease in children. World Congress of Paediatric Cardiology and Cardiac Surgery.
  • Celermajer, D. (2005). Primary and a half prevention: can we identify asymptomatic subjects with high vascular risk? (Editorial Comment). Journal of the American College of Cardiology, 45(12), 1994-1996. [More Information]
  • Sheil, M., Luxford, C., Davies, M., Peat, J., Nunn, G., Celermajer, D. (2005). Protein oxidation injury occurs during pediatric cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery, 130(4), 1054-1061. [More Information]
  • Celermajer, D. (2005). Putting patients first. 2nd Scientific Symposium, Dual ERA.
  • Celermajer, D. (2005). Quality of Life in Pulmonary Hypertension. 4th Scientific Symposium on Endothelin-Related Diseases.
  • Kilian, J., Nakhla, S., Griffith, K., Harmer, J., Skilton, M., Celermajer, D. (2005). Reperfusion injury in the human forearm is mild and not attenuated by short-term ischaemic preconditioning. Clinical and Experimental Pharmacology and Physiology, 32(01-Feb), 86-90. [More Information]
  • Lattimore, J., Wilcox, I., Nakhla, S., Langenfeld, M., Jessup, W., Celermajer, D. (2005). Repetitive hypoxia increases lipid loading in human macrophages-a potentially atherogenic effect. Atherosclerosis, 179(2), 255-259. [More Information]
  • Kilian, J., Celermajer, D., Adams, M. (2005). Safety of coronary angioplasty to chronic total occlusions. International Journal of Cardiology, 103(3), 256-258. [More Information]
  • Celermajer, D. (2005). Selective endothelin-A antagonism is not superior to dual endothelin antagonism in the treatment of pulmonary artery hypertension. American Thoracic Society annual scientific sessions.
  • Chow, C., Mou, D., Patel, A., Celermajer, D. (2005). The role of the 12-lead ECG as a screening test for cardiac source of embolus. Heart, Lung and Circulation, 14(4), 242-244. [More Information]
  • Keech, A., Grieve, S., Patel, A., Griffiths, K., Skilton, M., Watts, G., Marwick, T., Groshens, M., Celermajer, D. (2005). Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy. Diabetic Medicine, 22(11), 1558-1565. [More Information]
  • Kwok, T., Chook, P., Tam, L., Qiao, M., Woo, J., Celermajer, D., Woo, K. (2005). Vascular dysfunction in Chinese vegetarians: an apparent paradox? Journal of the American College of Cardiology, 46(10), 1957-1958. [More Information]

2004

  • Kerridge, I., Stewart, G., Raper, M., Celermajer, D., Willcock, S. (2004). "The Future of Medicine" - What is wrong with medicine today? and Where is the future of medicine?.
  • Celermajer, D. (2004). Androgens and atherosclerosis. International Society for Heart Research Scientific Sessions.
  • Celermajer, D. (2004). Androgens and the heart. Endocrine Society Of Australia.
  • Celermajer, D. (2004). Childhood obesity and atherosclerosis – keynote Lecture. South African Heart Association.
  • Celermajer, D. (2004). Cholesterol lowering and atherosclerosis. International Clinical Trials Symposium.
  • Celermajer, D. (2004). Closing holes in the heart percutaneously – state of the art. SAARC annual scientific sessions.
  • Thomas, G., Chook, P., Qiao, M., Huang, X., Leong, H., Celermajer, D., Woo, K. (2004). Deleterious Impact Of "High Normal" Glucose Levels And Other Metabolic Syndrome Components On Arterial Endothelial Function And Intima-Media Thickness In Apparently Healthy Chinese Subjects: The CATHAY Study. Arteriosclerosis, Thrombosis, and Vascular Biology, 24(4), 739-743.
  • Heather, A., McGrath, K., Sader, M., Nakhla, S., Jessup, W., Handelsman, D., Celermajer, D. (2004). Dihydrotestosterone Promotes Vascular Cell Adhesion Molecule-1 Expression In Male Human Endothelial Cells Via A Nuclear Factor-κB-Dependent Pathway. Endocrinology, 145(4), 1889-1897.
  • Celermajer, D. (2004). Dual cholesterol inhibition. South African Heart Association.
  • Woo, K., Chook, P., Yu, C., Sung, R., Qiao, M., Leung, S., Lam, C., Metreweli, C., Celermajer, D. (2004). Effects Of Diet And Exercise On Obesity-Related Vascular Dysfunction In Children. Circulation, 109(16), 1981-1986.
  • Celermajer, D. (2004). Fetal origins of atherosclerosis. South African Heart Association.
  • Woodman, R., Celermajer, D., Thompson, P., Hung, J. (2004). Folic Acid Does Not Improve Endothelial Function In Healthy Hyperhomocysteinaemic Subjects. Clinical Science, 106(4), 353-358.
  • Celermajer, D. (2004). Following the sick aorta. Cardiac Society of Australia and New Zealand.
  • Ng, M., Celermajer, D. (2004). Glucocorticoid treatment and cardiovascular disease. Heart, 90(Aug.), 829-830.
  • Celermajer, D. (2004). Interventions for adults congenital heart disease. South African Heart Association.
  • Skilton, M., Ho, L., Gosby, A., Caterson, I., Celermajer, D. (2004). Maternal Undernutrition And Early Postnatal Diet Affect Aortic Structure And Composition In Rats. Journal of the American College of Cardiology, 43 Abstracts(5), 517A-517A.
  • Celermajer, D., Greaves, K., Puranik, R., O'Leary, J. (2004). Myocardial Tissue Velocities In The Normal Left And Right Ventricles: Relationships And Predictors. Heart, Lung and Circulation, 13(4), 367-373.
  • Woo, K., Chook, P., Yu, C., Sung, R., Leung, S., Qiao, M., Lam, C., Metreweli, C., Celermajer, D. (2004). Overweight In Children Is Associated With Arterial Endothelial Dysfunction And Intima-Media Thickening. International Journal of Obesity, 28(7), 852-857.
  • Celermajer, D. (2004). The endothelium for cardiologists. Cardiac Society of Australia and New Zealand.
  • Sullivan, D., Celermajer, D., Le Couteur, D., Lam, C. (2004). The Vascular Implications Of Postprandial Lipoprotein Metabolism. Clinical Biochemist Reviews, 25(1), 19-30.
  • Celermajer, D. (2004). Vascular biology and obesity – Keynote Lecture. 6th Hong Kong East Meets West Symposium.

2003

  • Celermajer, D. (2003). ACE-inhibitors and long-term outcomes. Satellite to the American Heart Association.
  • Celermajer, D. (2003). Ageing and cardiovascular disease. Life Extension Symposium.
  • Ng, M., Quinn, C., McCrohon, J., Nakhla, S., Jessup, W., Handelsman, D., Celermajer, D., Heather, A. (2003). Androgens Up-Regulate Atherosclerosis-Related Genes in Macrophages From Males But Not Females: Molecular Insights Into Gender Differences in Atherosclerosis. Journal of the American College of Cardiology, 42(7), 1306-1313. [More Information]
  • Greaves, K., Mou, D., Patel, A., Celermajer, D. (2003). Clinical criteria and the appropriate use of transthoracic echocardiography for the exclusion of infective endocarditis. Heart, 89(3), 273-275.
  • Celermajer, D. (2003). Clinical Trials: Evidence and Unanswered Questions Hypertension. Cerebrovascular Diseases, 16(Suppl. 3), 18-24.
  • Celermajer, D., Deanfield, J. (2003). Congenital heart disease in adolescents and adults. (CHD in Adolescence). In Anderson RH, Tynan M, Rigby M (Eds.), Paediatric Cardiology, (pp. 1893-1925). London: Churchill Livingstone.
  • Sheil, M., Cartmill, T., Nunn, G., Sholler, G., Raitakari, O., Celermajer, D. (2003). Contrast echocardiography: potential for the in-vivo study of pediatric myocardial preservation. The Annals of Thoracic Surgery, 75(5), 1542-1549.
  • Ng, M., Nakhla, S., Baoutina, A., Jessup, W., Handelsman, D., Celermajer, D. (2003). Dehydroepiandrosterone, an adrenal androgen, increases human foam cell formation. Journal of the American College of Cardiology, 42(11), 1967-1974. [More Information]
  • Celermajer, D., Deanfield, J. (2003). Diseases of the tricuspid valve. In Anderson RH, Tynan M, Rigby M (Eds.), Paediatric Cardiology, (pp. 1111-1133). London: Churchill Livingstone.
  • Liu, P., Wishart, S., Celermajer, D., Jimenez, M., Di Pierro, I., Conway, A., Handelsman, D. (2003). Do reproductive hormones modify insulin sensitivity and metabolism in older men? A randomised, placebo-controlled clinical trial of recombinant human chorionic gonadotropin. European Journal of Endocrinology, 148(1), 55-56.
  • Griffiths, K., Sader, M., Skilton, M., Harmer, J., Celermajer, D. (2003). Effects of Raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease. Journal of the American College of Cardiology, 42(4), 698-704.
  • Celermajer, D. (2003). Heart disease in Australia. Royal Society of New South Wales, Melbourne: University of Melbourne.
  • Celermajer, D. (2003). Molecular effects of androgens on the vasculature. Cardiology Grand Rounds, Oxford: Oxford University Press.
  • Langenfeld, M., Simmons, L., McCrohon, J., Raitakari, O., Lattimore, J., Hennessy, A., Celermajer, D. (2003). Nitric Oxide does not Mediate the Vasodilation of Early Human Pregnancy. Heart, Lung and Circulation, 12(3), 142-148.
  • Celermajer, D. (2003). Non-invasive detection of atherosclerosis. Eleventh Annual Spring Desert Cardiovascular Update.
  • Lattimore, J., Celermajer, D., Wilcox, I. (2003). Obstructive sleep apnea and cardiovascular disease. Journal of the American College of Cardiology, 41(9), 1429-1437.
  • Sader, M., Griffiths, K., Skilton, M., Wishart, S., Handelsman, D., Celermajer, D. (2003). Physiological testosterone replacement and arterial endothelial function in men. Clinical Endocrinology, 59(1), 62-67.
  • Greaves, K., Bye, P., Parker, G., Celermajer, D. (2003). Prevalence of haemoptysis in adults with pulmonary atresia and ventricular septal defect, and the role of mammary artery collateral vessels. Heart, 89(8), 937-938.
  • Lau, A., Leichtweis, S., Hume, P., Mashima, R., Hou, J., Chaufour, X., Wilkinson, B., Hunt, N., Celermajer, D., Stocker, R. (2003). Probucol promotes functional reedothelialization in balloon-injured rabbit aortas. Circulation, 107(15), 2031-2036.
  • Celermajer, D. (2003). Sex and the heart. 24th Panhellenic Cardiological Conference.
  • Celermajer, D. (2003). Size of plaque doesn't matter. Eleventh Annual Spring Desert Cardiovascular Update.
  • Puranik, R., Celermajer, D. (2003). Smoking and Endothelial Function. Progress In Cardiovascular Diseases, 45(6), 443-458.
  • Celermajer, D. (2003). Statins, skin, and the search for a test of endothelial function. Journal of the American College of Cardiology, 42(1), 78-80.

2002

  • Celermajer, D. (2002). Angiotensin II and atherogenesis. Canadian Vascular Biology Working Group.
  • Kilian, J., Keech, A., Adams, M., Celermajer, D. (2002). Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coronary Artery Disease, 13(3), 155-159.
  • Sader, M., Celermajer, D. (2002). Endothelial function, vascular reactivity and gender differences in the cardiovascular system. Cardiovascular Research, 53, 597-604.
  • Freedman, B., Brieger, D., Celermajer, D., Chalmers, J., Tofler, G., Campbell, T., Feneley, M., Marwick, T., Muller, D., Tonkin, A. (2002). Global cardiology comes to Australia: 14th World Congress of Cardiology, Sydney, 5-9 May 2002. Medical Journal of Australia, , 473-475.
  • Corretti, M., Anderson, T., Benjamin, E., Celermajer, D., Charbonneau, F., Creager, M., Deanfield, J., Drexler, H., Gerhard-Herman, M., Herrington, D., et al (2002). Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International brachial Artery Reactivity Task Force. Journal of the American College of Cardiology, 39(2), 257-265.
  • Celermajer, D. (2002). International Cardiovascular Professor Program – Pfizer Canada – lecture tour of Vancouver. Lecture tour of Vancouver.
  • Woo, K., Chook, P., Chan, L., Cheung, A., Fung, W., Qiao, M., Lolin, Y., Thomas, G., Sanderson, J., Metreweli, C., Celermajer, D. (2002). Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplmentation. The American Journal of Medicine, 112(7), 535-539.
  • Sader, M., Miller, L., Caine, D., McCredie, R., Corr, M., Robertson, M., Watson, J., Celermajer, D. (2002). Neuropsychological and psychiatric outcomes following coronary surgery or angioplasty: a comparative study. Heart, Lung and Circulation, 11(2), 95-101.
  • Heather, A., Nakhla, S., McGrath, K., Martell, S., Yue, D., Celermajer, D., Jessup, W. (2002). Nitroglycerin upregulates matrix metalloproteinase expression by human macrophages. Journal of the American College of Cardiology, 39(12), 1943-1950.
  • Celermajer, D. (2002). Non-invasive detection of presymptomatic atherosclerosis. Hong Kong College of Cardiology Annual Scientific Sessions.
  • Wilson, S., Best, P., Edwards, W., Holmes, D., Carlson, P., Celermajer, D., Lermin, A. (2002). Nuclear factor-kappaB immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis, 160(1), 147-153.
  • Dzau, V., Bernstein, K., Celermajer, D., Cohen, J., Dahlof, B., Deanfield, J., Diez, J., Drexler, H., Ferrari, R., van Gilst, W., et al (2002). Pathophysiologic and therapeutic importance of tissue ACE. Cardiovascular Drugs and Therapy, 16(2), 149-160.
  • Ng, M., Liu, P., Williams, A., Nakhla, S., Ly, L., Handelsman, D., Celermajer, D. (2002). Prospective study of effect of androgens on serum inflammatory markers in men. Arteriosclerosis, Thrombosis, and Vascular Biology, 22(7), 1136-1141.
  • Celermajer, D. (2002). Size (of plaque) doesn't matter – the new biology of atherosclerosis. South African Cardiac Society.
  • Celermajer, D. (2002). Size of plaque and atherosclerosis risk. Hong Kong College of Cardiology Annual General Meeting.
  • Celermajer, D., Greaves, K. (2002). Survivors of coarctation repair: fixed but not cured. Heart, 88, 113-114.
  • Celermajer, D. (2002). Understanding the pathophysiology of the arterial wall: which method should we choose? European Heart Journal, 4(September), F24-F28.
  • Celermajer, D. (2002). Unresolved questions in hypertension. European Stroke Association Annual Scientific Sessions.

2001

  • Ly, L., Zhuang, T., Celermajer, D., Handelsman, D., Jimenez, M., Conway, A. (2001). A double-blind, placebo-controlled, randomised clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. Journal of Clinical Endocrinology and Metabolism, 86, 4078-4088.
  • Sader, M., Griffiths, K., Handelsman, D., Celermajer, D., McCredie, R. (2001). Androgenic anabolic steroids and arterial structure and function in male body builders. Journal of the American College of Cardiology, 37, 224-230.
  • Celermajer, D. (2001). Angiotensin and Vascular Biology. Taiwanese Heart Association Symposium.
  • Celermajer, D. (2001). Brachial artery ultrasound and atherosclerosis. Australasian Society for Ultrasound in Medicine.
  • Premawardhana, U., Adams, M., Yue, D., Celermajer, D., Birrell, A. (2001). Cardiovascular structure and function in baboons with Type 1 diabetes - a transvenous ultrasound study. Journal of Diabetes and Its Complications, 15, 174-180.
  • Langenfeld, M., Nakhla, S., Death, A., Jessup, W., Celermajer, D. (2001). Endothelin-1 and oxidized low density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cells. Clinical Science, 101, 731-738.
  • Heather, A., Jessup, W., Celermajer, D., Langdenfeld, M., Nakhla, S. (2001). Endothelin-1 plus oxidized low-density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cells. Clinical Science, 101, 731-738.
  • Celermajer, D. (2001). Evidence-based medicine: how good is the evidence? Medical Journal of Australia, 174, 293-295.
  • Celermajer, D. (2001). Impact of New Diagnostic and Intervention Options on Prognosis in Coronary Disease. International Congress of Life and Health Assurance.
  • Seale, J., Celermajer, D., Raitakari, O. (2001). Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. The American Journal of Cardiology, 87, 217-219.
  • Celermajer, D., Jarvisalo, M., Jartti, L., Nanto-Salonen,, K., Irjala, K., Ronnemaa, T., Hartiala, J., Raitakari, O. (2001). Increased aortic intime-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation, 104, 2943-2947.
  • Sader, M., Griffiths, K., Handelsman, D., Celermajer, D., McCredie, R., Wishart, S. (2001). Oestradiol improves arterial endothelial function in health men receiving testosterone. Clinical Endocrinology, 54, 175-181.
  • Sader, M., McCredie, R., Griffiths, K., Wishart, S., Handelsman, D., Celermajer, D. (2001). Oestradiol improves arterial endothelial function in healthy men receiving testosterone. Journal of the American College of Cardiology, 54, 175-181.
  • Ng, M., Jessup, W., Celermajer, D. (2001). Sex-related differences in the regulation of macrophage cholesterol metabolism. Current Opinion in Lipidology, 12, 506-510.
  • Celermajer, D., Woo, J., Woo, K., Leung,, S., Chook, P., Liu,, B., Ip,, R., Ho, S., Chan, S., Feng, J. (2001). The Mediterranean score of dietary habits in Chinese populations in four different geographical areas. European Journal of Clinical Nutrition, 55, 215-220.
  • Dzau, V., Bernstein, M., Celermajer, D. (2001). The Relevance of tissue ACE: manifestations in mechanistic and endpoint data. The American Journal of Cardiology, 88, 1-20.
  • Woo, K., Chook, P., Chan, W., So, W., Cockram, C., Celermajer, D. (2001). Type I diabetes and arterial dysfunction in asymptomatic Chinese adults. Diabetes Care, 24, 173.

2000

  • Celermajer, D. (2000). ACE inhibition and atherogenesis. International tissue ACE symposium.
  • Premawardhana, U., Celermajer, D. (2000). Advances in echocardiography. Internal Medicine Journal, 30, 360-366.
  • McCrohon, J., Death, A., Nakhla, S., Jessup, W., Handelsman, D., Stanley, K., Celermajer, D. (2000). Androgen receptor expression is greater in macrophages from male than from female donors. Circulation, 101, 224-226.
  • Celermajer, D. (2000). Benefits of Aggressive Lipid Lowering. Indonesia Atherosclerosis Society.
  • Raitakari, O., McCredie, R., Letters, J., Witting, P., Griffiths, K., Sullivan, D., Stocker, R., Celermajer, D. (2000). Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults. Free Radical Biology and Medicine, 28, 1100-1105.
  • McCrohon, J., Woo, K., Celermajer, D. (2000). Comparison of endothelial function in Caucasian and Chinese women before and after the menopause. Maturitas, 35, 31-37.
  • Celermajer, D. (2000). Early Detection of Atherosclerosis. South African Heart Association.
  • Raitakari, O., Celermajer, D. (2000). Flow-mediated dilatation. British Journal of Clinical Pharmacology, 50, 397-404.
  • Rasko, J., Celermajer, D. (2000). Gene therapy for vascular diseases. In RT Dean, D Kelly (Eds.), Atherosclerosis: Gene Expression, Cell Interactions, and Oxidation, (pp. 112-136). Oxford: Oxford University Press.
  • Celermajer, D. (2000). Inflammation in coronary disease. WHF Cardiology Year 2000 Course.
  • Miller, O., Tang, S., Keech, A., Pigott, N., Beller, E., Celermajer, D. (2000). Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomised double-blind study. The Lancet, 356(9240), 1464-1469.
  • Hornung, T., Celermajer, D., Sholler, G., Miller, O. (2000). Is nitric oxide implicated in pulmonary arteriovenous fistula formation? Pediatric Cardiology.
  • Graham, T., Bernardel, G., Mellen, B., Celermajer, D. (2000). Long term outcome in congenitally corrected transposition of the great arteries. Journal of the American College of Cardiology, 36(1), 255-261.
  • Celermajer, D. (2000). New techniques for detecting coronary atherosclerosis. European Society of Cardiology.
  • Celermajer, D. (2000). Nitric Oxide and Atherosclerosis. Hong Kong College of Cardiology Annual Scientific Sessions.
  • Celermajer, D. (2000). Nitric Oxide and the arterial endothelium. Taiwan Cardiac Society.
  • Celermajer, D. (2000). Obesity and Vascular Disease. South African Heart Association.
  • Raitakari, O., Adams, M., McCredie, R., Griffiths, K., Stocker, R., Celermajer, D. (2000). Oral vitamin C and endothelial function in smokers: acute improvement, but no sustained beneficial effect. Journal of the American College of Cardiology, 35, 1616-1621.
  • Raitakari, O., Adams, M., McCredie, R., Griffiths, K., Stocker, R., Celermajer, D. (2000). Oral vitamin C and endothelial function in smokers: short-term improvement, but no sustained beneficial effect. Journal of the American College of Cardiology, 35, 1616-1621.
  • Simons, L., Von Konigsmark, M., Simons, J., Celermajer, D. (2000). Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy post-menopausal women. The American Journal of Cardiology, 85, 1297-1301.
  • Raitakari, O., Lai, N., Griffiths, K., McCredie, R., Sullivan, D., Celermajer, D. (2000). Preserved endothelial function and enhanced peripheral vasodilation in humans after a fatty meal. Journal of the American College of Cardiology, 36, 417-422.
  • Lau, A., Witting, P., Chaufour, X., Celermajer, D., Pettersson, K., Stocker, R. (2000). Protective effects of probucol in two animal models of atherosclerosis. Redox Report, 5, 116-118.
  • Celermajer, D. (2000). Recent advances in atherosclerosis. Lebanese Heart Association.
  • Celermajer, D. (2000). Risk factors for Australian children. Medical Journal of Australia, 173, S11-12.
  • Millane, T., Bernard, E., Jaeggi, E., Uren, R., Cartmill, T., Hawker, R., Homan-Giles, R., Celermajer, D. (2000). Role of ischemia and infarction in the late right ventricular dysfunction following atrial repair of transposition of the great arteries. Journal of the American College of Cardiology, 35, 1661-1668.
  • Celermajer, D. (2000). Sex Steroids and the Heart. South African Heart Association.
  • Raitakari, O., Celermajer, D. (2000). Testing for endothelial dysfunction. Annals of Internal Medicine, 32, 293-304.
  • Celermajer, D. (2000). The effects of risk factors and race on endothelial function. International Atherosclerosis Society.
  • Celermajer, D. (2000). The Endothelium and Angiotensin. American Heart Association. High Blood Pressure Research, American Heart Association: American Heart Association.
  • Woo, K., Chook, P., Leong, H., Huang, X., Celermajer, D. (2000). The impact of heavy passive smoking on arterial endothelial function in modernized Chinese. Journal of the American College of Cardiology, 36, 1228-1232.
  • Celermajer, D. (2000). The role of antioxidants in atherosclerosis. International Faculty on Endothelial Function.
  • Premawardhana, U., Hoskins, M., Celermajer, D. (2000). Transvenous ultrasound in baboons; a novel window to the cardiovascular system. Clinical Science, 99, 141-147.
  • Celermajer, D., Vita, J. (2000). Vascular dysfunction and its contribution to atherogenesis. In RT Dean, D Kelly (Eds.), Atherosclerosis: Gene Expression, Cell Interactions, and Oxidation, (pp. 88-111). Oxford: Oxford University Press.

To update your profile click here. For support on your academic profile contact .